Accenture plc (ACN) — Council Assessment

🟡 WATCH · Score 62/100 · medium confidence

A genuinely high-quality, capital-light franchise (26% ROIC, 15.6% FCF margin) trading ~37% off its high with real DCF upside — but decelerating organic growth, aggressive debt-funded M&A, and an unresolved AI-disruption question keep it short of a clean pass.

As of 2026-10-01. 19 lenses weighed in, 0 abstained. Sources: 8 filings, 29 news, 30 discussion, 1 earnings_call.

360 narrative — news & sentiment digest

Accenture (ACN) Briefing

Management commentary (earnings call)

Q3 FY2026 (ended May 31, 2026) Results:

• Revenue $18.7B (+6% USD, +3% local currency). Organic growth tempered by ~$100M Middle East headwind (consulting-focused) and indirect global impact in discretionary spend from regional conflict.
• Consulting revenues +1% LCY; managed services +5% LCY.
• Operating margin expanded 20bps to 17%; EPS grew 9% to $3.80.
• New bookings $19.3B (book-to-bill 1.0); consulting book-to-bill 1.1.
• Free cash flow $3.6B; returned $2.2B to shareholders (Q3).

Strategic Moves & Guidance:

• Acquisitions announced: Dragos (OT cybersecurity platform, anchor), RunZero, NetRise; combined $208M ARR growing 48%. Total M&A spend now $9B for FY26 (up from prior $5B).
• Accenture Edge launch: New mid-market business targeting $300M–$3B revenue companies; $240B addressable market, high-single-digit growth.
• AI narrative: 100 additional clients initiated advanced AI projects; large enterprise AI programs (not just pilots) accelerating; $100M+ bookings reached 104 YTD (+13% vs FY25 comparator).
• OT cyber rationale: Positioned as AI enabler; cyber is "critical infrastructure" protection for physical AI and IoT at scale.

FY26 (Full Year) Outlook:

• Revenue 3–4% growth LCY (1% federal drag; excluding federal, 4–5%).
• Operating margin 15.8% (+20bps expansion).
• Adjusted EPS $13.78–$13.90 (+7–8% growth).
• Free cash flow $10.8–$11.5B; $9.5B+ returned to shareholders.
• Will access long-term debt for M&A liquidity while maintaining investment-grade rating.

Q4 FY26 Outlook:

• Revenue $17.75–$18.4B (1–5% growth LCY, ~-0.5% FX headwind).
• "More of the range is in play" due to macro uncertainty; Middle East indirect impact expected to persist into Q4.
• Consulting expected to return to growth in Q4 (low single digits full year); managed services also low single digits.

Tone: Management candid about near-term macro friction but confident in underlying AI demand fundamentals. Julie Sweet emphasized "green shoots" of larger AI programs among clients with mature digital cores; cited 104 $100M+ bookings as depth-of-relationship indicator. Acknowledged managed services deals pushed to FY27 and ongoing federal business headwinds but framed both as temporary/cyclical.

---

Recent developments

• June 18, 2026 (Q3 earnings release): Announced acquisition of majority stake in Dragos + full acquisitions of RunZero and NetRise (OT cybersecurity platform consolidation). Combined $9B acquisition spend expected for FY26.
• Accenture Edge launch (imminent): New business unit targeting mid-market; integration with Avanade (Microsoft JV).
• Promoted 124,000 employees (30% increase YoY); >900 to managing director level.
• Dividend increase: Quarterly cash dividend raised 10% to $1.63/share.
• Middle East conflict impact: ~$100M revenue headwind in Q3 (consulting, split domestic/indirect); sales delays in EMEA cited as ongoing drag.

---

Bull narrative

• AI demand inflection: Retail and press acknowledge "green shoots"—clients graduating from pilots to production, moving toward larger transformation programs (BT Group, Stellantis, Mitsubishi Chemical examples cited). Bookings growth (+5% LCY YTD) and $100M+ client count (+13% YoY) suggest enterprise reinvestment appetite.
• High-growth M&A: OT cyber platform (48% ARR growth) and Accenture Edge capture new TAM ($240B mid-market opportunity) outside legacy consulting saturation. Non-FTE platform models may improve margin profile longer term.
• Margin expansion proof: 8 consecutive quarters of operating margin growth; 9% EPS growth despite 3% revenue growth signals operational leverage.
• Free cash flow strength: 1.30 FCF/NI ratio; $10.8–$11.5B guidance supports $9.5B+ shareholder returns. Balance sheet intact for M&A.
• Ecosystem strength: Revenue from top 10 AI/data partners outpacing overall growth; bookings from Databricks, Palantir, Snowflake, OpenAI partnerships on track to double vs FY25.
• Valuation reset: Stock down ~50% YTD (per Motley Fool reference) creates entry point for dividend yield (5%) + potential recovery if AI-enabler narrative validates.

---

Bear narrative

• Growth deceleration masked by macro noise: 3% local-currency growth, 1% excluding federal, is modest. Management blames Middle East ($100M) and pushed-out managed services deals (~$2B), but skeptics note consulting bookings at 1.1x book-to-bill is modest, and converting bookings to revenue remains unproven at scale.
• AI revenue opacity: Accenture stopped breaking out AI bookings/revenue after Q1 FY26 (last reported $2.2B AI bookings). "Total bookings" is now the only proxy for AI demand; skeptics worry management is obscuring slowing AI adoption.
• Integration risk on mega-M&A: $9B spend (Dragos, RunZero, NetRise, Alpha Health, Whaler) is aggressive. Stitching three OT cyber assets into "one contract" is optimistic; margin accretion timing and execution track record questioned (Truist cut PT post-Q3).
• Mid-market TAM unproven: Accenture Edge is early-stage ("back record with Avanade" cited, but no revenue yet). Mid-market is fragmented and price-sensitive; legacy enterprise playbook may not scale there.
• Discretionary spend headwind persistent: "Longer decision-making" in EMEA and indirect global impact in Q3 extended into Q4 guidance range. Suggests client hesitation beyond regional conflict—broader budget uncertainty.
• FY27 outlook soft: 3–6% LCY growth guidance (vs. historical 5–7%) and margin outlook (15.9–16.1%) imply flattish EPS growth even with $9B M&A inorganic contribution ~2%. Dead-money risk if integration stumbles.
• Sentiment: "Show me stock" (per retail); funds allegedly prefer "fast growing money losers" (AI chip/cloud plays). June -50% drawdown was partly valuation reset, but skepticism on consulting-model resilience in AI-dominated future persists.

---

Retail sentiment

Mixed-to-cautiously-bullish, conviction low:

• Post-earnings (Oct 1): "Can't believe I missed this at the bottom, beautiful setup" and "long march back to $300 begins" signal tactical relief rally (+10%+ post-earnings). Optimists cite bookings beat (22.2B vs 19.9B expected) as proof of demand.
• June sell-off residue: "Dead money, best case grind years, worst case zeroed" and "AI-disruption trade" narrative dominates bearish chatter. References to "DEI silliness" and internal morale issues (MD silence on LinkedIn) suggest cultural friction.
• Dividend appeal: Some longs cite 5% yield + buyback as "way out there" bearish position; dividend defensibility cited as insurance.
• Options activity: Jun 26 unusual put/call volume post-guidance cut; Jun 26 $125 calls flipped 87% ROI in ~22 days, suggesting event-driven trading rather than conviction.
• Sector rotation concern: "Massive destruction of wealth across software/professional services" narrative; $ACN lumped in with devalued enterprise software on "regime change" AI bet.

Overall tone: Relief rally on earnings beat masks deeper unease about long-term consulting model viability. Retail showing tactical interest, not conviction.

---

Caveats

• Incomplete visibility: Accenture stopped disclosing AI bookings/revenue after Q1 FY26; total bookings now proxy for AI demand, not confirmed. No segment-level AI margin data.
• Macro opacity: Middle East impact quantified ($100M direct, indirect unspecified); EMEA "longer decision-making" not detailed by industry/customer. Q4 range so wide (1–5% LCY) as to be non-committal.
• M&A track record mixed: Truist PT cut post-Q3 suggests sell-side skepticism on integration execution. Dragos/RunZero/NetRise integration untested; no profitability targets disclosed.
• Mid-market unproven: Accenture Edge is launch-stage; no revenue guidance, margin targets, or customer-acquisition playbook disclosed. "Seamless integration" with Avanade is assertion, not fact.
• Booking-to-revenue conversion: Consulting book-to-bill 1.1 is healthy, but backlog conversion velocity not disclosed. Managed services deals pushed to FY27 may indicate lumpy realization.
• Analyst coverage: Limited depth in call Q&A; mostly on macro/M&A rationale. No probing on AI revenue attachment rates, consulting margin trajectory, or Accenture Edge unit economics.
• News sourcing: GuruFocus, TradingView, Yahoo Finance chatter is real-time noise; substantive institutional commentary sparse post-earnings.

---

Summary for council: Accenture beat Q3 bookings and revenue but faces macro headwinds and earnings-visibility erosion (AI segmentation hidden). $9B M&A spend (OT cyber, mid-market) targets new TAM but carries integration risk. Retail sentiment is tactical relief post-earnings, not renewed conviction. Management's AI-tailwind thesis is plausible but unproven at stated scale; margin expansion track record is real, but FY27 3–6% growth guidance signals decelerating organic momentum. Dividend and buyback offer downside cushion. Valuation reset (-50% YTD) prices in significant disruption; upside requires AI program acceleration and M&A accretion to validate.

Bull case

Accenture is an elite franchise: ROIC 26.2% vs WACC ~9.8%, FCF of $10.87B exceeding net income (FCF/NI ~1.42x), capex under 1% of revenue, and durable switching-cost moats in multi-year managed services (deferred revenue $6.5B+, growing). At $183 vs the fact base's $274 base-case DCF (and $224 bear case still above price), the market is pricing near-zero AI upside and no credit for OT-cyber TAM — a genuine margin of safety. Quality lenses (Buffett 74, Mauboussin 72, Munger 72) and the valuation referee (74) see a wonderful business at a fair-to-attractive price, supported by a 10% dividend raise and $7.5B buyback. If Accenture becomes the enterprise AI integrator (104 $100M+ bookings YTD), the thesis re-rates meaningfully.

Bear case

The majority of lenses landed on Watch, and the concerns rhyme: organic growth is decelerating (3-yr CAGR 4.2%, FY26 3-4% LCY, FY27 3-6%), consulting — the high-margin leg — grew just 1% LCY in Q3. The core labor-arbitrage model is precisely what agentic AI threatens to commoditize, and management stopped disclosing AI bookings after Q1 FY26 — opacity flagged by nearly every lens. The $9B FY26 M&A spend (up from $5B guidance) is funded partly by a new ~$5B debt issuance (per the 8-K filed 2026-07-10), shifting a net-cash fortress toward leverage into a decelerating-growth environment with no disclosed profitability targets. 'Business optimization' charges have recurred four straight years. On EPV (Greenwald ~$147) the stock is ABOVE intrinsic value, and the DCF leans 71.7% on terminal value — the upside is assumption-dependent.

Dissent — where the council disagrees

Two poles bracket the quality consensus. Walter Schloss (AVOID 22) is the sharpest dissent: this is asset-light and goodwill-heavy, P/B 3.64 with tangible book near zero after stripping goodwill, no hard-asset floor, and newly added debt — categorically not a value-with-protection situation; his point matters because it exposes that the entire bull case rests on forecasted cash flows and a moat that AI may erode, not on anything you can liquidate. Pulling the other way, Buffett, Munger, Mauboussin and the valuation referee (all ~72-74) argue the quality is real and the price finally offers a margin of safety. The decisive tension: the bulls' upside depends on the same AI-integrator thesis that is currently UNVERIFIABLE because management stopped disclosing the key metric — and Druckenmiller's broken-tape point (-37% from high) warns against stepping in before price confirms. Greenwald's EPV ($147, below price) is the most uncomfortable number for the bulls and deserves weight: strip out the terminal-value speculation and the margin of safety thins dramatically.

Key risks

• AI/agentic automation structurally compressing the billable-hour consulting model over a 5-10 year horizon — core revenue-per-engagement erosion
• Opacity: AI bookings/revenue disclosure discontinued after Q1 FY26, removing the key metric needed to verify the AI-enabler thesis
• $9B FY26 M&A (Dragos/RunZero/NetRise) funded partly by ~$5B new debt (8-K 2026-07-10), with no disclosed profitability targets and unproven integration
• Decelerating organic growth (FY27 guide 3-6% LCY vs historical 5-7%) with the high-margin consulting leg at only ~1% LCY
• Recurring 'business optimization' charges four consecutive years (~$2.4B cumulative) that flatter adjusted EPS vs GAAP
• DCF intrinsic value is 71.7% terminal value and rests on sustained relevance; EPV (~$147) sits below the current price

Catalysts

• Resumption of AI bookings/revenue disclosure showing acceleration
• Organic (local-currency) growth reaccelerating toward 5%+ with consulting returning to growth
• Disclosed margin accretion and integration milestones on the OT-cyber acquisitions
• Continued margin expansion and large shareholder returns ($9.5B+ guided, 10% dividend raise, $7.5B buyback)
• Price confirmation / base-building that would satisfy a tape-sensitive entry

DCF valuation (finance-expert model)

two-stage DCF, Gordon terminal value, CAPM-weighted WACC.

Intrinsic value: $274.14/share vs price $183.37 → +50% (bear $224.26 · base $274.14 · bull $342.7).

Step	Value
Base free cash flow	$10.9B
FCF growth (yrs 1-5)	4.2% (revenue CAGR)
WACC (β 1.092)	9.8%
Terminal growth	2.5%
PV of explicit FCF	$46.6B
PV of terminal (residual) value	$118.3B (72% of EV)
Enterprise value	$165.0B
less Net debt	$-9.6B
= Equity value	$174.6B
/ Shares (637M) = intrinsic/share	$274.14

Short-sell evaluation

🚫 AVOID SHORTING

Despite decelerating growth, AI-disruption overhang, rising leverage and recurring 'one-time' charges, Accenture is a poor short. The forensic short-seller himself scored it only a Watch (52) and explicitly said this is NOT a classic Chanos candidate: OCF ($11.47B) and FCF ($10.87B) both exceed GAAP net income, earnings are cash-backed, margins are expanding, and the balance sheet is investment-grade with prodigious FCF. The stock is already 37% off its high with a DCF base case ($274) and even bear case ($224) above the current price, plus a 10% dividend raise and $7.5B buyback providing downside support — shorting into that cash-return floor and conservative embedded expectations is unfavorable asymmetry. The disruption thesis is a multi-year, slow-burn question, not a near-term catalyst, so the short carries carry cost and squeeze risk without a timed trigger.

Pros (the short could work)

• Decelerating organic growth (FY27 3-6% LCY) against a model structurally exposed to AI automation of billable hours
• Disclosure opacity (AI bookings dropped after Q1 FY26) and recurring 'business optimization' charges flatter adjusted EPS vs GAAP
• Aggressive debt-funded M&A ($9B spend, ~$5B new notes) with no profitability targets — integration/goodwill-impairment risk
• DCF leans 71.7% on terminal value and EPV (~$147) is below price, implying downside if the AI-enabler thesis fails to materialize

Cons (what kills the short)

• Earnings quality is pristine: OCF and FCF both exceed net income — no accrual red flag to exploit
• Strong FCF ($10.87B), investment-grade balance sheet, 10% dividend raise and $7.5B buyback create a downside floor
• Already down ~37% from highs with base ($274) and bear ($224) DCF above current price — poor risk/reward for a short
• Durable switching-cost moat and the plausible bull case (AI integrator) create meaningful squeeze/re-rating risk; disruption is a slow-burn, not a dated catalyst

Council scorecard

Lens	School	Stance	Score	Conf
Warren Buffett	quality	🟢 pass	74	medium
Valuation Referee (Damodaran-style)	referee	🟢 pass	74	medium
Michael Mauboussin	quality	🟢 pass	72	medium
Charlie Munger	quality	🟢 pass	72	medium
Chuck Akre	quality	🟡 watch	62	medium
Terry Smith (Fundsmith)	quality	🟡 watch	62	medium
Philip Fisher	growth	🟡 watch	58	medium
Bruce Greenwald	value	🟡 watch	58	medium
Howard Marks	risk	🟡 watch	55	medium
Ray Dalio	risk	🟡 watch	52	medium
AI & Disruption Referee (Christensen-style)	referee	🟡 watch	52	medium
Stanley Druckenmiller	risk	🟡 watch	52	medium
Benjamin Graham	value	🟡 watch	52	high
Joel Greenblatt	value	🟡 watch	52	medium
Seth Klarman	value	🟡 watch	52	medium
Peter Lynch	growth	🟡 watch	52	high
Forensic Short-Seller (Chanos/Einhorn-style)	referee	🟡 watch	52	medium
Paul Singer	value	🟡 watch	48	medium
Walter Schloss	value	🔴 avoid	22	high

Member reasoning

Warren Buffett — 🟢 pass · 74/100 · medium confidence

Accenture is a high-quality professional services business with genuine competitive advantages — primarily switching costs, scale, brand trust, and a deep talent ecosystem — that fit squarely within a Buffett-style quality framework. The economics are understandable: sell human capital and increasingly technology-enabled services to large enterprises under multi-year contracts, earn consistent margins, and convert earnings to free cash flow. The moat is real but not impenetrable, and the current transition toward AI-enabled delivery and the $9B M&A push introduce meaningful uncertainty that keeps this from a high-conviction pass.

Moat Assessment: Accenture's moat derives from client switching costs (deep integration into client operations, proprietary data, and institutional knowledge), brand and trust with C-suite buyers, global delivery scale (700,000+ professionals across 120+ countries), and an ecosystem of partnerships with major technology vendors (Databricks, Palantir, OpenAI, Microsoft/Avanade). The 10-K for FY2025 shows operating margin of 14.68% and ROE of 24.88% and ROIC of 26.17% — all consistent with a business earning above its cost of capital. FCF margin of 15.61% in FY2025 (up from 13.27% in FY2024) confirms real cash conversion. Revenue CAGR of ~4.2% over 3 years is modest but consistent. These are characteristics I admire — steady, predictable, high-returning.

Owner Earnings Quality: FY2025 operating cash flow of $11.47B against capex of only $600M (per fundamentals block) yields free cash flow of $10.87B — a FCF/net income ratio of approximately 1.42x, a clear sign the business is not a capital trap. Maintenance capex is genuinely low relative to revenues ($600M capex on $69.7B revenue is under 1%). This is a labor-intensive, asset-light model — close to ideal for owner earnings.

Capital Allocation — Mixed: Management has returned capital consistently via buybacks and dividends (10% dividend increase to $1.63/quarter announced per narrative; $7.5B+ buyback program for FY2026 per the June 23, 2026 8-K). Share count has been declining, contributing to EPS growth. However, the $9B FY2026 M&A program — anchored by Dragos and OT cybersecurity assets — is a red flag for me. Paying aggressive prices for fast-growing but early-stage acquisitions (48% ARR growth, $208M combined ARR) at an implied multiple that is very high introduces acquisition-premium risk. Accenture has historically been a disciplined buyer of small bolt-ons, but $9B in one year is a meaningful step-up. Truist cut its price target post-Q3 per the narrative, suggesting sell-side skepticism on integration. The July 2026 $5B bond issuance (per 8-K filed July 10, 2026) to fund M&A introduces leverage where the balance sheet was previously clean — I prefer self-funding over borrowing to buy assets at peak AI enthusiasm prices.

Balance Sheet Shift: The July 2026 debt issuance ($5B at 4.75%-5.6% coupons maturing 2029-2036, per the 8-K) materially changes the balance sheet. The fundamentals block shows cash of $9.65B and null debt-to-equity as of the most recent period, but post-issuance net debt will move substantially. The FY2026 full-year guidance of $9.5B+ in shareholder returns alongside $9B in M&A while issuing $5B in bonds suggests a tight capital allocation. I am cautious when a company stretches its balance sheet simultaneously for M&A and buybacks.

Valuation: The DCF intrinsic value is $274.14 per share against a current price of $183.37 — a 49.5% upside. Even the bear-case DCF of $224.26 implies meaningful undervaluation. P/E of 14.61x and price-to-FCF of 10.32x on trailing numbers are genuinely attractive for a business with 24%+ ROE and 26%+ ROIC. The 52-week low of $118.15 and current price 37% below the 52-week high of $291.09 suggest the market has materially de-rated the stock. At price-to-sales of 1.61x and price-to-FCF of 10.32x, I am paying a fair price for a wonderful business — not a wonderful price, but not overvaluation either. The margin of safety versus the base DCF is real.

AI Disruption Risk (My Frame): This is the central long-term question. Accenture earns its living deploying human expertise; AI could compress headcount-intensive billable work. However, the evidence from the narrative suggests Accenture is positioning as the AI integrator rather than the target — its clients need help implementing AI, not just buying it. The 104 $100M+ AI bookings YTD and 8 consecutive quarters of margin expansion suggest the model is adapting. I cannot fully model whether AI transforms consulting economics over 10 years, and that uncertainty is why I do not score this higher. The moat may be durable but it is not fortress-level in an AI-saturated world.

Management Candor: The 8-K disclosures on business optimization costs ($615M in FY2025 Q4 for severance and asset impairments related to two divested acquisitions per the 2025 10-K) show management willing to admit strategic mistakes (divesting acquisitions 'no longer aligned with strategic priorities'). The non-GAAP adjustments are extensive but reconciled clearly. I prefer simplicity, but the disclosures are not opaque.

Conclusion: At ~10x FCF and 14.6x earnings with 26% ROIC and genuine switching-cost moats, Accenture earns a qualified pass. The deductions come from: (1) $9B M&A at potentially elevated prices with uncertain integration outcomes; (2) new debt issuance to fund capital allocation simultaneously; (3) genuine AI disruption risk to the consulting model over a decade; (4) 3-4% organic growth that is modest for a 'wonderful business' premium. A wonderful business at a fair-to-attractive price, with real but not fully quantifiable execution risk on the transformation strategy.

Key points

• FY2025 FCF of $10.87B vs. capex of $600M yields a price-to-FCF of 10.32x — genuine asset-light owner earnings quality (fundamentals block)
• ROE 24.88%, ROIC 26.17% — sustained well above cost of capital without historical heavy leverage (fundamentals block)
• Revenue CAGR 4.2% over 3 years; FCF margin improved to 15.61% in FY2025 from 13.27% in FY2024 — margin trajectory is right direction (fundamentals history block)
• DCF intrinsic value $274/share vs. $183 current price; even bear-case $224 implies ~22% margin of safety (valuation block)
• Dividend raised 10% to $1.63/quarter; $7.5B buyback program FY2026; share count declining (8-K filed June 23, 2026 and narrative)
• Deep switching costs via multi-year managed services contracts and embedded client relationships; 10-K confirms deferred transition costs and contract asset structure (2025 10-K filing)

Red flags

• $9B FY2026 M&A spend including Dragos/RunZero/NetRise (OT cyber) with $208M combined ARR at 48% growth — implies very high acquisition multiples and integration risk at scale (narrative/Q3 commentary)
• July 2026 $5B bond issuance at 4.75%-5.6% coupons to fund M&A (8-K filed July 10, 2026) introduces meaningful leverage where balance sheet was previously clean — debt-to-equity now non-negligible
• Business optimization charges recurring: $1.5B over FY2023-FY2024, then another $615M in FY2025 Q4 for fresh headcount reductions and asset impairments (2025 10-K) — suggests strategy execution friction
• AI disruption risk: consulting model is ultimately headcount-leveraged; AI-driven productivity compression could erode billable hours moat over a 10-year horizon — not fully quantifiable but material
• Accenture stopped disclosing AI bookings/revenue after Q1 FY2026 (narrative) — reduced transparency is contrary to the candid management disclosure I prize
• Organic revenue growth of only 3-4% LCY in FY2026 guidance with FY2027 guidance of 3-6% LCY is modest for a business priced on quality multiples; requires M&A to hit growth targets

Valuation Referee (Damodaran-style) — 🟢 pass · 74/100 · medium confidence

Accenture's current price of $183.37 sits approximately 33% below the fact base's base-case DCF intrinsic value of $274.14 per share, and even the bear-case sensitivity of $224.26 implies ~22% upside. This creates meaningful margin of safety that survives conservative sensitivity adjustments. The story-to-numbers conversion is straightforward: Accenture is a mature, capital-light professional services firm with durable ROIC well above WACC, consistent FCF generation, and a plausible (if not exciting) organic growth trajectory. Let me work through the key value drivers.

Growth assumptions: The DCF uses a 4.19% FCF growth rate anchored to the 3-year revenue CAGR. Actual revenue grew from $50.5B (FY2021) to $69.7B (FY2025) — a real 4.2% CAGR — and FY2026 guidance implies 3-4% local currency growth (narrative, Q3 FY2026 commentary). This is conservative: it does not require heroic assumptions. The reverse-engineered implied growth at $183.37 is even more modest — the market is pricing in something closer to 2-3% terminal-era growth, which is plausible in a scenario where consulting faces secular pressure from AI. I am comfortable the growth assumption is achievable and does not demand a heroic narrative.

Margins and ROIC: Operating margin of 14.7% (FY2025 10-K), FCF margin of 15.6% (FY2025), and ROIC of 26.2% (fundamentals block) all comfortably exceed the WACC of 9.76% used in the DCF. ROIC/WACC spread of ~16 percentage points is genuine value creation, not accounting noise. Capex is remarkably low at $600M on $69.7B revenue (10-K, FY2025), confirming the asset-light model. The sales-to-capital ratio is implicitly very high, which is internally consistent with the growth assumed — professional services grow via human capital and contract wins, not fixed-asset deployment. This is not a fantasy; it reflects the actual economics.

Terminal value risk: The DCF terminal growth rate of 2.5% is at the upper end of defensible nominal GDP growth for a mature firm. Damodaran's discipline would push this toward 2.0-2.5% for a company of this maturity in a competitive sector, so 2.5% is aggressive but not egregious. The terminal value accounts for 71.7% of enterprise value — this is a standard finding for stable cash-flow businesses and not itself a red flag, though it means terminal assumptions dominate. At a 2.0% terminal growth instead of 2.5%, intrinsic value would compress somewhat but likely still materially above $183.

WACC assessment: The 9.76% WACC uses a beta of 1.09 and what appears to be an equity-only cost of capital (debt_to_equity is null in the fundamentals block, suggesting minimal net debt). With $9.6B cash and the new $5B senior note issuance (8-K filed 2026-07-10: $4.979B net proceeds at rates of 4.75%-5.6%), Accenture is transitioning from net-cash to modest net-debt to fund its $9B M&A program. This modestly reduces WACC through the debt tax shield but adds financial risk. A 9.76% cost of equity/WACC is reasonable for a beta ~1.1 business; not implausibly low.

Reinvestment quality concern: The $9B FY2026 M&A program (Dragos, RunZero, NetRise, per narrative) is significant. Historical acquisition spending: $6.5B in FY2024 (10-K), $2.5B in FY2023, $3.4B in FY2022 — so $9B is a step-change. Goodwill on those FY2024 acquisitions was $5.3B of $6.5B spend (10-K), implying ~82% goodwill-to-consideration — high, raising fair-value-creation risk. Intangible amortization rising from $441M (FY2023) to $746M (FY2025) per the 10-K confirms the M&A cadence is being digested. Whether $9B in OT cybersecurity and mid-market assets earns above WACC is unverified — no profitability targets disclosed per the narrative caveats. This is a genuine red flag: value-destructive M&A at scale could impair what otherwise looks like a clean intrinsic value story.

AI disruption assessment: AI is a double-edged factor for Accenture's valuation. On the upside, the narrative reports 104 $100M+ AI-related bookings YTD (+13% vs. FY25 comparator) and partnerships with Databricks, Palantir, Snowflake, OpenAI positioned to drive implementation demand. On the downside, AI could automate significant portions of the labor arbitrage and code/analysis work that forms the lower-margin consulting base — directly compressing billable hours needed to sustain growth. The DCF assumes ~4% growth with flat-to-improving margins; if AI disrupts ~15-20% of billable labor over 5 years (plausible for rote coding, data tasks), the growth assumption requires offsetting price/mix improvement. Management's narrative about AI enabling larger transformation programs (not just pilots) is the key offset, but this is not yet proven at sufficient scale. For valuation purposes, the conservative DCF growth rate (4%) partially prices this risk in; the bear case ($224) adds additional cushion. Net: AI is a meaningful but not existential near-term valuation risk given the margin of safety at current price.

Margin of safety: At $183.37 vs. $224.26 bear / $274.14 base / $342.70 bull, the stock trades ~18% below even the bear case. This is genuine, not manufactured, margin of safety. Even if I mark down the terminal growth to 2.0% and add 50bps to WACC for execution risk on the $9B M&A, intrinsic value likely remains above $200. The price implies very modest expectations — essentially no credit for AI upside or OT cybersecurity TAM expansion. This is a Damodaran-style bargain zone: decent business, conservative growth priced in, room for positive surprise.

Key uncertainty: The $9B M&A integration risk is the primary input that could shift stance from pass to watch. If these acquisitions destroy value (ROIC < WACC on deployed capital), the FCF trajectory could disappoint and the margin of safety narrows. The narrative flags this explicitly and Truist cut its price target post-Q3. I am keeping this as a pass but with medium confidence rather than high.

Key points

• Base-case DCF intrinsic value $274.14 vs. current price $183.37 — 49.5% upside; even bear-case sensitivity of $224.26 implies ~22% upside, providing genuine margin of safety
• ROIC of 26.2% vs. WACC of 9.76% — substantial value-creating spread confirmed by 10-K FY2025 financials; FCF margin 15.6% on $69.7B revenue is durable
• Revenue CAGR of 4.2% (FY2021–FY2025 per fundamentals history) used as DCF growth rate — conservative, historically grounded, does not require heroic assumptions
• Asset-light model confirmed: capex only $600M on $69.7B revenue (10-K FY2025); high sales-to-capital ratio is internally consistent with assumed growth
• Operating margin guidance 15.8% for FY2026 (+20bps vs. FY2025) and 8 consecutive quarters of margin expansion per narrative support convergence story
• Terminal growth at 2.5% is at upper bound of defensible range for a mature firm but terminal value (71.7% of EV) sensitivity is partially offset by the large margin of safety
• Dividend raised 10% to $1.63/quarter (per narrative); $9.5B+ shareholder returns guided for FY2026 — cash returns partially de-risk the hold period
• Reverse-engineered implied market growth at $183 appears to price in near-zero AI upside and no credit for OT cybersecurity TAM — any positive surprise is unpriced

Red flags

• $9B FY2026 M&A program (Dragos, RunZero, NetRise per narrative) is aggressive step-change from historical $2.5-6.5B pace; FY2024 acquisitions show ~82% goodwill-to-consideration ratio (10-K FY2024: $5.32B goodwill on $6.46B consideration), raising risk that capital is deployed at or below WACC
• No profitability targets or ROIC expectations disclosed for new acquisitions per narrative caveats — value accretion is asserted, not demonstrated; integration of three OT cyber assets into one contract untested
• Terminal value constitutes 71.7% of enterprise value — small errors in terminal growth or WACC assumptions have outsized impact; 2.5% terminal growth rate is at the upper limit of what Damodaran discipline would sanction for a competitive services firm
• Accenture stopped breaking out AI bookings/revenue after Q1 FY2026 per narrative — reduces ability to track whether AI investments are earning above cost of capital or simply growing the top line
• $4.979B senior note issuance (8-K July 2026) at 4.75%-5.6% rates adds financial leverage to fund M&A; introduces interest cost drag and modest balance sheet risk not reflected in the pre-issuance DCF net-debt assumption
• Consulting revenue +1% LCY in Q3 FY2026 (narrative) — the highest-margin segment is growing least; if AI structurally compresses consulting realization rates, operating margin expansion thesis stalls
• Business optimization charges: $615M in FY2025 (10-K) and $308M in first 9 months of FY2026 (10-Q filed June 2026) — recurring 'one-time' charges signal ongoing structural cost pressure, not just cyclical adjustment

Michael Mauboussin — 🟢 pass · 72/100 · medium confidence

Accenture passes the Mauboussin quality screen on the core scorecard — ROIC comfortably above WACC, a genuinely wide (if not unassailable) moat with multiple reinforcing mechanisms, and a current price that embeds expectations below the base rate of what this franchise has historically delivered. The key tension is whether the moat is strengthening or eroding as AI restructures the consulting value chain, and whether the $9B FY26 M&A program represents disciplined capital allocation or empire-building. On balance, the embedded expectations appear conservative enough to offer a margin of safety across most scenarios, but confidence is constrained by opacity around AI revenue segmentation and M&A integration track record.

ROIC vs. WACC: The fact base reports ROIC of 26.2% (fundamentals block) against a CAPM-derived WACC of 9.76% (valuation block). The spread is ~1,640bps — wide by almost any comparison set. ROE is 24.9%. FCF margin of 15.6% (FY2025, per fundamentals) and operating margin of 14.7% are stable and slightly expanding (Q3 FY26 operating margin 17%, +20bps per narrative). This is not a thin-spread story; it is a franchise earning meaningfully above its cost of capital across a multi-year history. The 3-year revenue CAGR of 4.2% with sustained FCF margins ($8.4B to $10.9B, 2024→2025, per fundamentals history) is consistent with a business not in margin compression. The base rate concern is that professional services ROIC is structurally high due to human capital leverage (low fixed assets) but mean-reverts as pricing power erodes; the question is the mechanism protecting Accenture's spread.

Moat assessment — Wide, Stable-to-Eroding: Four real moat mechanisms are present, each with a specific mechanism I can point to:

1. Switching costs (primary): Large managed-services and outsourcing contracts are structurally sticky — deferred transition costs on the balance sheet ($862M as of Aug 31, 2024 per 10-K filed 2024-10-10), multi-year duration, and contractual early-termination protections. Clients who have embedded Accenture into mission-critical operations (ERP, cloud migration, managed infrastructure) face procedural, relational, and financial costs to switch. Deferred revenues of $6.1B current + $642M non-current (Aug 2025, 10-K filed 2025-10-10) and $13.1B receivables signal a large, recurring contract base. Q3 FY26 10-Q reports deferred revenues of $6.5B current + $1.0B non-current (May 31, 2026), growing, suggesting the sticky backlog is expanding.
2. Supply-side scale economies: $70B revenue firm with global delivery centers, sector-specific talent pools, and proprietary accelerators/platforms. Fixed cost absorption across a workforce of ~780K creates a cost structure smaller competitors cannot replicate. R&D spend of $817M in FY2025 (10-K filed 2025-10-10) — down from $1.15B in FY2024 and $1.3B in FY2023 — is being reoriented toward AI tooling, which if successful creates proprietary methodologies.
3. Intangibles — brand and relationships: Client tenure at the Fortune 500 level creates institutional trust that is genuinely hard to dislodge; 104 clients with $100M+ bookings YTD (narrative) represents relationship depth, not just transaction volume. The Avanade JV with Microsoft (referenced in narrative) creates a channel-locked ecosystem advantage.
4. Ecosystem/partner network effects (indirect): Revenue from top 10 AI/data partners (Databricks, Palantir, Snowflake, OpenAI) growing faster than overall (narrative) suggests Accenture is a preferred implementation layer — creating a two-sided dynamic where hyperscalers prefer routing enterprise deals through Accenture, reinforcing client stickiness.

Trajectory is the harder call. The moat is stable on managed services (switching costs intact) but potentially eroding on consulting, where AI could compress the human-hours-per-deliverable that underpins consulting economics. The bear case on AI disruption is real and specific: if GenAI tools allow clients to internalize work previously outsourced, or if a new entrant (cloud-native AI consultancy) can deliver equivalent outcomes with 10x fewer people, Accenture's labor-based economics deteriorate. The offsetting thesis — that Accenture is itself the AI integrator and thus benefits from the transition — is plausible (104 $100M+ bookings, AI narrative) but opacity exists: management stopped disclosing AI bookings after Q1 FY26 (narrative caveat), making this hypothesis difficult to verify from the fact base.

Expectations investing — price embeds modest expectations: The DCF intrinsic value is $274/share (base), current price $183, implying 49.5% upside (valuation block). The sensitivity range is $224 (bear) to $343 (bull). At $183, the implied FCF growth rate of 4.2% (the DCF's own assumption, sourced from revenue CAGR) is already conservative relative to Accenture's historical FCF generation. The P/FCF of 10.3x (fundamentals) is low for a franchise of this ROIC profile — implying either the market expects FCF to compress, or the stock is genuinely undervalued. P/E of 14.6x and P/S of 1.61x are also below historical norms for a business with 15%+ FCF margin and 26% ROIC. The 52-week drawdown of 37% from the high implies the market has meaningfully revised down embedded expectations. The stock is now pricing in something closer to a commoditized services firm than a high-ROIC franchise — which is the opportunity, if the moat holds.

Working backwards: at $183 and ~$10.9B base FCF, with WACC 9.76%, a ~4% perpetual growth would roughly justify the price. That is the base rate for a mature professional services firm — implying no credit for AI-enablement upside, no credit for OT cyber platform ARR growth (48% per narrative on Dragos), and no credit for Accenture Edge TAM. If those optionalities exist and the moat is merely stable (not eroding), the price embeds a margin of safety.

Capital allocation judgment — mixed but not alarming: FY2026 M&A program at $9B (up from $5B guidance, per narrative) raises empire-building concerns. The Dragos acquisition (OT cybersecurity, $208M ARR combined, 48% growth) looks rational — acquiring into a fast-growing adjacent TAM before AI commoditizes core consulting. But $9B is 83% of FY2025 FCF; this is a large capital commitment on unproven integration track record. The 10-K (filed 2025-10-10) discloses $615M in FY2025 business optimization costs including $271M in asset impairments for divested Americas acquisitions 'no longer aligned with strategic priorities' — suggesting prior M&A produced some value destruction. That said, buybacks remain active ($7.5B FY26 program per June 2026 8-K), dividends were raised 10% (narrative), and the July 2026 debt issuance of ~$5B (8-K filed 2026-07-10) appears designed to fund M&A while preserving liquidity — not undisciplined leverage. Net cash position remains positive ($9.6B cash, no debt-to-equity ratio disclosed but the DCF uses net debt of negative $9.6B, implying net cash). Overall capital allocation is mixed: shareholder returns are generous, M&A is bold and partially risky, organic reinvestment (R&D declining) warrants monitoring.

Distribution of outcomes: Bull (30% probability) — AI enabler thesis validates, Dragos/OT cyber platform contributes 2-3% inorganic revenue, managed services sticky through cycle, FCF grows 7-8% — stock re-rates to $300+. Base (45%) — 4-5% FCF growth, moat stable, M&A breaks even, stock grinds to $230-270 over 3 years with dividends and buybacks. Bear (25%) — AI disrupts consulting faster than integration captures, managed services contracts lost to hyperscaler-native competitors, M&A writedowns, FY27 growth misses — stock revisits $120-130 lows. The fat tail is AI disruption, which is binary in probability but not in magnitude — it would play out over years, not quarters, giving a reasonably long window to observe and adjust.

AI disruption assessment: This is the central moat question, not a peripheral factor. Accenture sits at the intersection of the AI risk (labor hours compressed by LLMs) and the AI opportunity (being the integrator enterprises need to deploy AI). The balance is what drives the moat trajectory. Near-term evidence favors the opportunity thesis (bookings growing, large enterprise programs accelerating per narrative). Medium-term (5-10 year) risk is real: if AI dramatically reduces the human capital required per engagement, Accenture's supply-side scale advantage (which is fundamentally about deploying large skilled workforces) erodes. The FY2025 talent restructuring ($344M in severance for 'compressed timeline' headcount reduction, 10-K filed 2025-10-10) and simultaneous upskilling investment signals management is actively repositioning the workforce — this is the right process response, but the outcome is uncertain. The moat does not collapse; it evolves. That uncertainty is appropriately reflected in my medium confidence level.

Key points

• ROIC of 26.2% vs WACC of 9.76% represents a ~1,640bps spread — wide, historically sustained, and the primary basis for franchise value (fundamentals block; valuation block)
• Multiple reinforcing moat mechanisms: switching costs (deferred revenues $6.5B current + $1.0B non-current per Q3 FY26 10-Q), supply-side scale, brand/relationships (104 clients at $100M+ bookings), and ecosystem partner lock-in with hyperscalers
• At $183/share, price embeds ~4% perpetual FCF growth — conservative for a 26% ROIC franchise; DCF base case $274 implies 49.5% upside with a $224 bear case providing downside context
• P/FCF of 10.3x and P/S of 1.61x are anomalously low for a business generating 15.6% FCF margins with expanding operating margins (17% in Q3 FY26, per narrative) — expectations appear to discount significant franchise deterioration
• Business optimization costs of $615M in FY2025 including $344M severance and $271M asset impairments (10-K filed 2025-10-10) signal active workforce repositioning toward AI — right directional process, outcome uncertain
• $7.5B FY26 buyback program (8-K filed 2026-06-23) and 10% dividend increase provide material shareholder return floor while waiting for AI thesis to resolve

Red flags

• Management stopped disclosing AI bookings/revenue after Q1 FY26 (narrative caveat) — eliminates ability to verify the AI-enabler thesis quantitatively; total bookings is a crude proxy
• $9B FY26 M&A spend (83% of FY2025 FCF) raises capital allocation risk; prior acquisitions resulted in $271M impairments (10-K 2025-10-10), and Dragos/RunZero/NetRise integration track record is unproven
• AI disruption risk to consulting labor economics is real and specific: if LLMs compress human-hours-per-deliverable, supply-side scale advantage (large workforce deployment) becomes a liability rather than a moat
• R&D declining ($1.3B FY2023 → $817M FY2025, per 10-K filings) even as AI investment is supposedly accelerating — net R&D investment may be contracting in real terms
• FY27 guidance of 3-6% LCY growth (narrative) is below historical 5-7% range and below what DCF requires to justify even the bear case intrinsic value; organic deceleration is confirmed
• July 2026 debt issuance of ~$5B (8-K filed 2026-07-10) introduces leverage into a previously net-cash balance sheet; interest burden of $229M in FY2025 was already up $170M YoY (10-K 2025-10-10) and will increase materially

Charlie Munger — 🟢 pass · 72/100 · medium confidence

Accenture is a high-quality professional services business that sits comfortably within the circle of competence: it is an IT consulting and managed services firm that earns its living by helping large enterprises transform their technology stacks, manage complex systems, and now implement AI. The economics are understandable in a paragraph. The moat is real — switching costs are enormous (multi-year managed services contracts, embedded delivery teams, proprietary methodologies, and 40+ years of client relationships at the C-suite level), and these show up as durable returns: ROIC of 26% and ROE of 25% (fundamentals block) sustained over a full cycle, well above any plausible cost of capital. FCF margin of ~15-16% and FCF conversion above 100% of net income confirm earnings quality. The balance sheet is conservative by professional-services standards — net cash position of ~$9.6B (cash_and_equivalents, 10-K filed 2025-10-10) against newly issued long-term debt of ~$5B (8-K filed 2026-07-10 documenting the note issuance), with no sign of a fragile or distressed structure. Capital allocation is owner-minded: $9.5B+ returned to shareholders in FY26 via buybacks and dividends (narrative, earnings call), dividend raised 10% to $1.63/quarter (narrative), and the share count is shrinking. Management's disclosure is reasonably candid — they called out the $615M business-optimization charge plainly (10-K filed 2025-10-10), quantified severance and asset impairments separately, and did not hide the Middle East revenue headwind. At the current price of $183.37, the stock trades at ~10x price-to-FCF and ~14.6x P/E — for a 26% ROIC business with durable switching-cost moat, this is a fair-to-attractive price, not a heroic multiple. The DCF intrinsic value (valuation block) pegs fair value at $274/share with a bear case of $224, implying ~22-49% upside at today's price — meaningful margin of safety for a quality compounder. The inversion test: how does this go to zero or permanently impair capital? The most plausible path is AI disintermediation — if generative AI automates away the consulting work that Accenture charges for, its moat erodes. This is a genuine risk and the source of the -37% decline from the 52-week high. However, the counter-evidence is in the data: Accenture is actually one of the primary integrators of enterprise AI, capturing $100M+ AI bookings from 104 clients YTD (narrative); managed services (long-term contracts) grew +5% LCY while consulting grew +1%, suggesting the stickier revenue base is holding. The bear case — consulting disintermediated by AI tools — is real but more likely to be a headwind to growth than an existential threat, given clients still need implementation, governance, and change management at scale. The main reservations that keep the score at 72 rather than 85: (1) the $9B M&A spend in FY26 including Dragos, RunZero, and NetRise (narrative) is aggressive and integration risk is real — management asserted but did not document profitability targets or integration timelines, which Munger would find unsatisfying; (2) organic revenue growth of ~4% CAGR (fundamentals, revenue_cagr) is modest for the multiple, and FY27 guidance of 3-6% LCY (narrative) is not the high-reinvestment-rate compounding machine Munger prizes most; (3) Accenture stopped disclosing AI bookings/revenue after Q1 FY26 (narrative/caveats) — a mild disclosure regression that warrants watching; (4) goodwill from acquisitions has been growing materially ($5.3B added in FY24 acquisitions alone per 10-K filed 2024-10-10) and tangible equity is thin, meaning ROTCE flatters the true capital intensity of the acquisition strategy. On balance: a high-quality business with a real moat, clean cash flows, honest-enough management, and a price that for the first time in years offers a genuine margin of safety. Not a perfect Munger compounder — growth is pedestrian and M&A execution is unproven — but the quality is genuine and the price is fair. Pass, with a watchful eye on M&A integration and AI revenue transparency.

Key points

• ROIC 26%, ROE 25% (fundamentals block) — sustained, high-quality returns well above cost of capital across a full economic cycle
• FCF of $10.87B on revenue of $69.7B = 15.6% FCF margin; FCF/net income >1.0x confirms earnings are backed by cash (10-K filed 2025-10-10, fundamentals block)
• Switching-cost moat is real and durable: multi-year managed services contracts, embedded global delivery teams, C-suite relationships — clients do not change primary consulting partners casually
• Price-to-FCF of 10.3x and P/E of 14.6x for a 26% ROIC business is a fair-to-attractive price; DCF bear case of $224 implies ~22% upside from $183 even under conservative assumptions (valuation block)
• Net cash ~$9.6B prior to July 2026 note issuance; even post-$5B debt raise, balance sheet remains serviceable for an investment-grade firm generating $10B+ FCF annually
• Owner-minded capital allocation: $9.5B+ returned in FY26, 10% dividend increase, shrinking share count — management acts like owners
• Managed services growing at +5% LCY is the stickier, higher-quality revenue base; Accenture is integrating AI rather than being replaced by it — 104 clients with $100M+ AI bookings YTD (narrative)

Red flags

• $9B M&A spend in FY26 (Dragos, RunZero, NetRise among others per narrative/8-K) is aggressive for a professional-services firm; no profitability targets or integration timelines disclosed — classic empire-building warning sign Munger would scrutinize
• Goodwill additions: $5.3B from FY24 acquisitions alone (10-K filed 2024-10-10); cumulative goodwill bloat on balance sheet means tangible ROIC is flattered — true capital intensity of the acquisition strategy is higher than headline ROIC suggests
• AI bookings/revenue disclosure discontinued after Q1 FY26 (narrative/caveats) — a mild step backward in transparency; total bookings now the only proxy for AI demand
• Organic revenue CAGR of ~4% (fundamentals, revenue_cagr_years=3) and FY27 guidance of 3-6% LCY is pedestrian for a business Munger would want to compound at high rates; growth engine is partially inorganic
• Business optimization charges recurring across multiple fiscal years ($1.5B in FY23-24 cycle, $615M in FY25 Q4 per 10-K filed 2025-10-10, $308M in FY26 H1 per 10-Q filed 2026-06-18) — serial restructuring is a quality-of-earnings concern
• AI disintermediation risk is genuine: if LLMs and AI agents automate routine consulting deliverables, pricing power and headcount-driven revenue model face structural headwind over 5-10 year horizon

Chuck Akre — 🟡 watch · 62/100 · medium confidence

Accenture is a genuine capital-light, high-FCF-conversion franchise with ROIC of 26% and ROE of 25% (10-K filed 2025-10-10), both well above cost of capital and not driven by financial leverage (debt-to-equity not calculable from filings but net cash position of $9.6B per fundamentals). This clears the first leg of the stool convincingly. The FCF conversion is exceptional: FY2025 FCF of $10.9B on revenues of $69.7B implies a 15.6% FCF margin, and FCF exceeded net income, confirming high-quality earnings (fundamentals data). Per-share FCF compounding has been solid: FCF grew from $8.4B in FY2021 to $10.9B in FY2025 while share count has been reduced via consistent buybacks ($9.5B+ returned to shareholders in FY26 guidance per narrative). The franchise moat — deep client relationships, global delivery scale, switching costs embedded in multi-year managed services contracts, and a recognized brand in enterprise transformation — is real and durable, reflecting genuine business economics rather than leverage. The reinvestment runway is where my conviction softens. Organic revenue CAGR of only 4.2% over three years (fundamentals) is modest for a business I would want to compound at a high rate. The $9B FY26 M&A program (Dragos, RunZero, NetRise, Alpha Health per narrative) is large and untested in profitability. The 10-K (2025-10-10) discloses $6.5B acquisition spend in FY2024 generating $5.3B of goodwill — a heavy premium-to-asset ratio that demands flawless integration. Goodwill amortization of intangibles rose to $746M in FY2025 from $530M in FY2024 and $441M in FY2023 (10-K 2025-10-10), signaling accelerating M&A pace with uncertain return on deployed capital. The OT cybersecurity acquisitions (combined $208M ARR, 48% growth) are interesting but represent a model shift toward platform-style businesses that Accenture has not historically operated — integration track record at this scale is unproven. Management quality is mixed by my standards. Capital allocation discipline is partially intact: buybacks have been consistent and the dividend was raised 10% (narrative), suggesting some alignment. However, the $9B M&A number, up from a prior $5B expectation (narrative), is empire-building in pace and scale. The stopping of AI bookings disclosure after Q1 FY26 (narrative caveat) is an integrity yellow flag — promotional non-GAAP framing and reduced transparency on the most-discussed growth vector is exactly what I watch for. Business optimization charges of $615M in FY2025 and $308M in the first nine months of FY26 (10-Q filed 2026-06-18) are recurring enough to question as a structural cost, not a one-time restructuring. On valuation, at $183.37 with price-to-FCF of 10.3x (fundamentals), Accenture is not expensive for a franchise of this quality — the DCF intrinsic value of $274/share implies ~50% upside at base case assumptions. At a 10x FCF multiple for a business compounding FCF at 7-8% per year with a 15%+ FCF margin, the price is arguably fair-to-cheap. The 52-week drawdown to $118 low and current price 37% below the 52-week high (price data) represents a genuine valuation reset. The AI disruption question is nuanced: Accenture could be a net beneficiary as the systems integrator enabling AI adoption at scale (104 $100M+ bookings YTD per narrative), but it also faces structural risk if AI automates the billable labor that underpins its consulting revenue model. The managed services segment (+5% LCY per narrative) is more defensible; consulting (+1% LCY) is the exposed leg. Overall: two of three legs are strong (franchise quality, reasonable current valuation). The reinvestment runway leg is uncertain — M&A pace is aggressive, organic growth is decelerating, and management transparency on AI monetization has actually declined. I would watch and revisit after seeing FY26 full-year results with Dragos integration milestones and resumed AI revenue disclosure.

Key points

• ROIC of 26.2% and ROE of 24.9% (fundamentals) are well above cost of capital and achieved without meaningful financial leverage — net cash of $9.6B (fundamentals) confirms returns are genuine business economics
• FCF of $10.9B in FY2025 on $69.7B revenue (15.6% FCF margin) with FCF exceeding net income signals high-quality, capital-light earnings conversion
• Consistent per-share value creation: share count reduced via $9.5B+ FY26 shareholder return program (narrative) and 10% dividend increase; FCF/share trajectory is positive
• Franchise moat is real — switching costs in multi-year managed services contracts, global delivery scale, and deep enterprise relationships create durable pricing power
• Valuation reset to 10.3x price-to-FCF (fundamentals) and ~37% below 52-week high creates a reasonable entry for a business of this quality; DCF base case of $274 implies meaningful upside
• Managed services (+5% LCY, narrative) is the more defensible and recurring revenue leg; AI as systems integrator could extend the reinvestment runway if enterprise adoption accelerates

Red flags

• Organic revenue CAGR of only 4.2% over three years (fundamentals) is modest — the reinvestment runway leg of the stool is not clearly open-ended at high rates of return
• $9B FY26 M&A spend (up from prior $5B expectation per narrative) is aggressive empire-building pace; intangible amortization rose to $746M in FY2025 from $441M in FY2023 (10-K 2025-10-10), signaling premium-priced acquisitions with uncertain ROIC
• Accenture stopped disclosing AI bookings/revenue after Q1 FY26 (narrative caveat) — reduced transparency on the most-hyped growth driver is an integrity yellow flag by my standards
• Business optimization charges are recurring: $615M in FY2025 Q4 (10-K 2025-10-10) and $308M in first nine months of FY26 (10-Q 2026-06-18); these appear structural rather than truly one-time, suggesting management overstates normalized earnings
• OT cybersecurity platform model (Dragos, RunZero, NetRise) is a significant business model departure from core consulting/managed services — integration execution risk is high and profitability targets were not disclosed (narrative)
• Consulting revenue growth of only +1% LCY in Q3 FY26 (narrative) is structurally vulnerable to AI automation of billable hours — the core labor model could face secular margin pressure over a 5-10 year horizon

Terry Smith (Fundsmith) — 🟡 watch · 62/100 · medium confidence

Accenture is a genuinely high-quality business by most Fundsmith criteria — high ROCE (~26% as reported in fundamentals), strong FCF conversion, asset-light model, and durable operating margins — but several concerns temper a clean 'pass.' The business optimization charges are recurring (fiscal 2023, 2024, and 2025 all featured material restructuring/optimization costs per the 10-K filings), which Smith treats as a red flag against trusting reported earnings at face value. More critically, the July 2026 8-K reveals Accenture raised ~$5B in long-term debt (floating rate notes plus fixed notes at 4.75–5.6%) from Accenture Capital Inc., and management has guided to $9B total M&A spend in FY26 (up from a prior $5B), including the Dragos/RunZero/NetRise OT cybersecurity platform consolidation. Smith's most explicit red flag is serial, debt-funded acquisitive growth — and this is precisely what Accenture is executing. Goodwill from acquisitions was already substantial ($5.3B in FY24 alone per the 2024 10-K), and intangible amortization rose to $746M in FY25 from $530M in FY24 (per the 2025 10-K), suggesting accelerating acquisition pace. On the positive side: FCF of $10.9B vs net income of $7.7B in FY25 gives outstanding cash conversion (FCF/NI ~1.41x), operating margins are stable at ~14.7% GAAP (guided to 15.8% for FY26), ROIC of 26% is well above cost of capital, capital expenditures are minimal ($600M capex vs $11.5B operating cash flow per fundamentals), and the revenue base is large-client, multi-year contracted, and diversified globally. The DCF model (10-K and valuation block) suggests ~49% upside to intrinsic value at $274/share base case, and the current P/FCF of 10.3x is genuinely undemanding for a business of this quality. However, the AI disruption question is non-trivial: Accenture's moat rests on trusted advisor relationships and systems integration expertise, but AI coding tools and agentic software could compress consulting day-rates and headcount per engagement over a 5–10 year horizon. Management's pivot to AI-enabled services is credible directionally, but the opacity (AI bookings no longer separately disclosed after Q1 FY26 per narrative) is a concern. The $9B M&A splurge for OT cybersecurity is a bet on platform adjacency that Smith would scrutinize hard — it is debt-funded, integration-heavy, and the combined $208M ARR at 48% growth is small relative to acquisition cost. Valuation is reasonable but not dirt-cheap on a quality basis; the stock is 37% below its 52-week high and 25% below one year ago, which creates margin of safety but also reflects genuine uncertainty about growth trajectory (FY27 guided 3–6% LCY, below historical 5–7%).

Key points

• Outstanding FCF conversion: FY25 free cash flow of $10.9B vs net income of $7.7B gives FCF/NI ratio of ~1.41x — Smith's cash conversion test passed cleanly (fundamentals block)
• ROIC of 26% well above cost of capital; sustained across multi-year history in fundamentals table (21%+ across 2021-2025)
• Asset-light model: capex of only $600M against $11.5B operating cash flow (FY25 fundamentals); business grows without heavy reinvestment in fixed assets
• Operating margin stable at ~14.7% GAAP (FY25 10-K); guided to 15.8% for FY26 with 8 consecutive quarters of expansion per narrative
• Current P/FCF of 10.3x and P/S of 1.61x are undemanding for quality; DCF base case of $274/share implies ~49% upside from $183 current price
• Revenue is large-enterprise, multi-year contracted, globally diversified — genuinely recurring and not highly economically sensitive in the short term
• Strong shareholder returns: $9.5B+ guided return to shareholders in FY26 (buybacks + dividends); 10% dividend increase to $1.63/share quarterly per narrative

Red flags

• Serial debt-funded M&A: $5B debt issuance in July 2026 (8-K filed 2026-07-10) to fund $9B FY26 M&A — precisely Smith's most disliked capital allocation pattern
• Goodwill and intangible amortization accelerating: intangible amortization jumped from $530M (FY24) to $746M (FY25) per 2025 10-K, signaling pace of acquisitions that obscures organic earnings quality
• Business optimization costs are recurring, not one-off: $1.06B in FY23, $438M in FY24, $615M in FY25 (per respective 10-Ks) — three consecutive years of 'exceptional' charges clouds true earnings power
• AI disruption risk to core model: agentic AI and coding automation could compress consulting billable hours per engagement over 3–10 years; Accenture's response (pivoting to AI enabler) is plausible but unproven at scale
• AI revenue opacity: management stopped disclosing AI-specific bookings/revenue after Q1 FY26 per narrative — reduces ability to verify whether AI-driven bookings are net new or cannibalizing legacy
• Revenue growth deceleration: 3-year CAGR of only 4.2% (fundamentals); FY27 guided 3–6% LCY — below historical 5–7%; mid-market Accenture Edge and OT cyber platforms are early-stage with no disclosed unit economics
• Debt load increasing from near-zero: long-term debt issuances in 2024 (S-3 registration) and $5B in July 2026 represent a structural shift away from the historically debt-free model Smith rewards

Philip Fisher — 🟡 watch · 58/100 · medium confidence

Accenture is a large-scale professional services and technology consulting firm with genuine growth credentials, but its profile sits uneasily against my strictest criteria. On the positive side, revenue has grown from $50.5B (FY2021) to $69.7B (FY2025) — a 3-year CAGR of ~4.2% per the fact base — with FCF margins holding in the 13–16% range and operating margins at ~14.7% (FY2025 10-K). Operating margin has expanded for eight consecutive quarters per management commentary, and ROIC of 26.2% is impressive. Management appears candid: they openly disclosed the $615M business optimization charge in Q4 FY2025 (including $344M severance and $271M asset impairments from divestitures), acknowledged Middle East headwinds quantitatively (~$100M Q3 FY2026), and disclosed that managed services deals slipped to FY27. That candor satisfies my integrity standard. The AI narrative is plausible — 104 bookings of $100M+ (up 13% YoY per narrative), partnerships with Databricks, Palantir, Snowflake, OpenAI accelerating — and management's framing of larger enterprise AI programs moving from pilot to production has the texture of real demand rather than pure promotion. However, several Fisher criteria are not well met. First, organic growth is modest: 3% local-currency growth in Q3 FY2026 with full-year guidance of 3–4% LCY is not 'above industry' growth — it is below what I expect for a compounder. The 3-year revenue CAGR of 4.2% does not excite me, particularly when management acknowledges a 1% federal drag and Middle East headwind; strip those away and the organic engine runs at perhaps 4–5%, which remains unspectacular for a company at this scale. Second, R&D investment has actually declined: the 10-K (FY2025 and FY2024) shows R&D costs fell from $1.30B (FY2023) to $1.15B (FY2024) to $817M (FY2025) — a dramatic cut. This is a serious Fisher red flag: R&D being cut just as AI is supposedly the transformational opportunity suggests management is substituting M&A for organic R&D, which is not my preferred route to durable growth. Third, the $9B FY2026 M&A spend (Dragos, RunZero, NetRise, Alpha Health, Whaler per narrative) is aggressive and introduces integration risk. I am not opposed to acquisitions that extend a genuine product franchise, but this pace — combined with declining R&D — raises the concern that revenue growth is increasingly bought rather than earned. The Accenture Edge mid-market initiative is intriguing but entirely unproven at this stage. Fourth, AI disruption risk is real and cuts both ways. Accenture could be an AI enabler (helping enterprises implement AI at scale), which is the bull case. But AI also threatens to automate significant portions of consulting and managed services labor — the very workforce Accenture is restructuring. The simultaneous severance actions and OT cyber acquisitions suggest management is navigating a genuine business model transition, not just riding a wave. The outcome over my preferred 5–10 year horizon is genuinely uncertain. The valuation (DCF intrinsic value $274 vs. current $183, ~49% upside; P/FCF 10.3x, P/E 14.6x) is reasonable and provides some margin of safety by my standards, but I do not buy 'cheap' alone — I need confidence in the multi-year growth runway, which here I do not fully have. The stock is 37% below its 52-week high, which could indicate opportunity or a fundamental repricing of the consulting model. On balance: strong management integrity, real FCF, credible AI tailwinds, but declining R&D, tepid organic growth, heavy M&A reliance, and genuine disruption uncertainty keep this in 'watch' territory rather than a clear Fisher pass.

Key points

• Revenue grew from $50.5B (FY2021) to $69.7B (FY2025), 3-year CAGR ~4.2% (fundamentals block), with FCF margins sustained in 13–16% range — a respectable but not exceptional organic growth profile
• ROIC of 26.2% and operating margin of ~14.7% (FY2025 10-K) indicate a well-managed cost structure with genuine returns on reinvested capital
• Management candor is strong: $615M business optimization charge disclosed granularly in FY2025 10-K ($344M severance, $271M asset impairments), Middle East headwind quantified, managed-services slippage acknowledged — satisfies my integrity criterion
• AI demand appears real at this stage: 104 bookings of $100M+ (up 13% YoY per narrative), large enterprise programs moving from pilot to production, ecosystem partnerships with Databricks/Palantir/Snowflake/OpenAI reportedly doubling
• Operating margin expanded for 8 consecutive quarters and EPS grew 9% on 3% revenue growth in Q3 FY2026 — demonstrates genuine operating leverage and cost discipline
• $7.5B share repurchase program (8-K June 23, 2026), 10% dividend increase, $10.8–11.5B FCF guidance for FY26 indicate strong capital return capability
• Accenture Edge (mid-market, $240B TAM) and OT cybersecurity platform (Dragos/RunZero/NetRise, 48% ARR growth per narrative) represent new market expansion attempts beyond legacy consulting saturation

Red flags

• R&D costs declined sharply: $1.30B (FY2023) → $1.15B (FY2024) → $817M (FY2025) per FY2025 and FY2024 10-Ks — a 37% cut in two years precisely when AI innovation is supposedly critical; this is a major Fisher concern about mortgaging the future
• Organic revenue growth of 3% LCY (Q3 FY2026) and full-year guidance of 3–4% LCY does not meet my 'above-industry, sustained' growth standard; FY27 guidance of 3–6% LCY is similarly uninspiring
• $9B M&A spend in FY2026 alone (narrative) suggests growth is increasingly acquisition-driven rather than earned; integration of Dragos, RunZero, NetRise, Alpha Health simultaneously carries significant execution risk with no profitability targets disclosed
• Accenture stopped disclosing AI-specific bookings/revenue after Q1 FY2026 (narrative caveat) — this reduces transparency precisely at the moment the AI thesis is most important to validate, which partially conflicts with my candor standard
• AI automation poses a genuine structural threat to Accenture's labor-intensive consulting and managed services model over a 5–10 year horizon; the business model transition is real and uncertain, not merely a cyclical headwind
• Consulting book-to-bill of 1.1x (narrative) is modest; managed services deals pushed to FY27 suggest demand is uneven and conversion velocity is slow — not the characteristics of a company in a strong growth phase
• PEG ratio of 3.49 (fundamentals) suggests the market is already pricing in meaningful growth recovery; at current prices there is DCF upside but limited margin of safety against a further growth deceleration

Bruce Greenwald — 🟡 watch · 58/100 · medium confidence

Accenture is a legitimate earnings-power business with a real operating history, so the EPV framework applies cleanly. The core question is whether EPV exceeds reproduction value (confirming a genuine franchise) and whether today's market price sits below EPV with an adequate margin of safety.

EPV Construction: Using FY2025 data from the 10-K (filed 2025-10-10): operating income $10.226B, operating margin 14.68%. The company has run a series of 'business optimization' charges — $615M in FY2025 Q4, $438M in FY2024, $1.063B in FY2023 (10-K filings). These are recurring enough that I treat them as quasi-structural friction (restructuring at this scale and frequency is not genuinely one-time), but the core earnings power should be normalized around the adjusted operating margin management targets (~15.8% guided for FY2026 per the narrative). Normalizing on FY2025 revenue of $69.7B at a 15.5% through-the-cycle margin (splitting the difference between reported 14.68% and adjusted ~15.8%) yields normalized EBIT ≈ $10.8B. Tax-affecting at 23.7% (FY2025 effective rate per 10-K): NOPAT ≈ $8.24B. Maintenance capex: PP&E capex was $600M (FY2025 fundamentals); depreciation on fixed assets was $622M (10-K); these are roughly matched, so no D&A add-back is needed — deferred transition amortization ($337M) and intangible amortization ($746M) are largely acquisition-driven and arguably below-the-line for EPV purposes, though the intangible amortization reflects real economic consumption of acquired assets. Using WACC of 9.76% (DCF block, CAPM-derived): EPV = $8.24B / 0.0976 ≈ $84.4B enterprise value. Adding net cash ($9.65B per fundamentals): equity EPV ≈ $94B, or roughly $147–148/share on ~637M shares outstanding. Current market price is $183.37, which is ~24% ABOVE the EPV estimate. There is no margin of safety at the current price on an EPV basis — the market is already pricing in growth.

Asset Reproduction Value Cross-Check: Book equity is $30.9B (fundamentals). Tangible reproduction cost is well below book given goodwill ($26B+ estimated from 10-K acquisition history — fiscal 2024 alone saw $5.3B goodwill added on $6.5B acquisitions). But the real reproduction value for a professional services franchise must also include: (a) the cost of assembling ~750,000+ skilled consultants with sector-specific knowledge, (b) brand/reputation built over decades, (c) global delivery infrastructure and client relationships embedded in long-term managed services contracts. These intangibles are genuinely costly to replicate but are also not on the balance sheet at anything near replacement cost. A rough reproduction value of $70–90B (enterprise) is plausible — meaningful but below the EPV estimate.

Moat Test: EPV ($84B EV) > estimated reproduction value ($70–90B range) — this is consistent with a franchise, though the margin is not overwhelming. The moat sources are identifiable and concrete: (1) customer captivity — multi-year managed services contracts with high switching costs (transition cost, embedded knowledge, regulatory risk), evidenced by $6.5B+ deferred revenues and large contract asset balances (10-Q filed 2026-06-18); (2) scale economies in delivery — global workforce and shared delivery centers create cost advantages small entrants cannot match; (3) ecosystem lock-in via technology partnerships (SAP, Microsoft/Avanade, Salesforce, AWS) that clients cannot easily replicate through point vendors. These are real but not impenetrable — Infosys, TCS, IBM, and Cognizant are credible substitutes.

Growth Question: The provided DCF (intrinsic $274/share) implies the stock is cheap, but this leans heavily on terminal value (71.7% of enterprise value per the DCF block) and a 4.19% WACC-beating growth rate in perpetuity. I distrust this as an anchor — the terminal value alone ($188B PV) dwarfs explicit-period FCFs. The EPV discipline says: do not pay for growth unless the franchise is so demonstrably protected that above-WACC returns are near-certain. Accenture's ROIC of 26.2% (fundamentals) is well above WACC of ~9.8%, which is a strong franchise signal — but the $9B M&A spend in FY2026 (narrative) is aggressively acquiring growth that is untested in OT cybersecurity (Dragos at 48% ARR growth but no profitability disclosed) and the mid-market (Accenture Edge is pre-revenue). Growth-funded acquisitions at this scale carry the risk that capital is being deployed at below-cost-of-capital returns if integration disappoints.

AI Disruption Assessment (through the EPV lens): AI is the central risk and opportunity. The bear case is that AI commoditizes the knowledge-transfer and project-staffing components of consulting — reducing the number of FTEs needed per engagement and compressing billing rates. The bull case is that Accenture is the systems integrator of AI for large enterprises, capturing transformation spend as AI is deployed at scale. From an EPV standpoint, the risk is that the moat sources (human capital, delivery scale) are being partially automated, which could compress normalized margins over a 3-10 year horizon. The FY2025 business optimization actions — $344M in severance for headcount reductions and AI-driven efficiency (10-K) — signal management is already repositioning, but this also confirms that the current cost structure is not stable. I cannot confidently normalize margins higher; the direction is uncertain and the restructuring frequency (three consecutive years) is itself a red flag for EPV stability.

Summary: Price ($183.37) > EPV (~$147/share). No margin of safety exists at current price on an EPV basis. The moat is real but not impenetrable. The DCF-based intrinsic value ($274) relies on terminal-value assumptions I discount heavily. The $9B M&A spend and AI disruption uncertainty make normalized earnings harder to anchor. This is a quality franchise at a price that already prices in significant growth — a 'watch' rather than a 'pass' until the price approaches or dips below the EPV estimate.

Key points

• EPV estimate ~$147/share (NOPAT ~$8.24B capitalized at 9.76% WACC, plus net cash) sits ~24% BELOW the current market price of $183.37 — no margin of safety on the conservative EPV metric
• Moat is real and identifiable: customer captivity via long-term managed services contracts (deferred revenues $6.5B+ per 10-Q 2026-06-18), scale economies in global delivery, and technology ecosystem lock-in with Microsoft/Avanade, SAP, and others
• ROIC of 26.2% vs WACC ~9.8% is a strong franchise signal confirming EPV > reproduction value — but this spread must be sustained, not assumed
• Business optimization charges in three consecutive fiscal years ($1.063B FY2023, $438M FY2024, $615M FY2025 per respective 10-Ks) are quasi-structural and complicate earnings normalization — these are not genuinely one-time
• DCF intrinsic value ($274/share) is 71.7% terminal value — exactly the long-horizon speculative assumption EPV methodology is designed to avoid; I do not anchor on it
• Free cash flow conversion is strong (FCF $10.87B vs net income $7.68B in FY2025, FCF margin 15.6%) supporting the earnings-power analysis, though capex light profile reflects the people-intensive model

Red flags

• Market price ($183.37) materially above EPV (~$147/share) — buyer is paying for growth, not just current earnings power; growth value is only justified inside a demonstrably protected franchise
• $9B M&A spend in FY2026 (narrative) is aggressive and includes untested platforms (Dragos OT cyber at undisclosed profitability, Accenture Edge pre-revenue) — capital deployment at potentially sub-WACC returns if integration fails
• AI disruption risk to the core moat: if AI automates knowledge-transfer and staffing intensity, normalized margins could compress below current levels, lowering EPV further; FY2025 headcount restructuring ($344M severance, 10-K) confirms management itself sees the workforce model changing
• Accenture stopped disclosing AI bookings/revenue after Q1 FY2026 (narrative) — reduced transparency makes it harder to assess whether AI transformation spend is accreting to Accenture's revenue or being captured by hyperscalers directly
• Recurring restructuring charges obscure true through-the-cycle earnings power — three consecutive years of 'optimization' costs suggest the cost structure is in structural transition, not episodic disruption
• Terminal value dependency in the provided DCF (71.7% of EV) is precisely the speculative long-horizon assumption EPV is designed to avoid; the provided $274 intrinsic value should not be treated as a margin-of-safety anchor

Howard Marks — 🟡 watch · 55/100 · medium confidence

Accenture presents a genuinely interesting risk/reward setup from a Marks perspective — the stock is down ~37% from its 52-week high and ~25% over the past year, and the DCF (10-K/10-Q filings, fundamentals block) suggests a base intrinsic value of ~$274/share versus a current price of ~$183, implying roughly 49% upside. At 14.6x trailing P/E, 10.3x price-to-FCF, and 1.6x price-to-sales, the multiple compression from peak has been substantial. The bear narrative is partially in the price: consulting model disruption fears, decelerated organic growth (3% LCY), federal headwinds, and macro uncertainty are all visible in the drawdown. FCF is real and large — $10.87B in FY2025 (10-K filed 2025-10-10), with FCF/net income ratio of ~1.42, confirming earnings quality. Operating cash flow of $11.47B versus capex of only $600M confirms the asset-light nature. The balance sheet, as of the most recent 10-Q (filed 2026-06-18), shows $9.65B cash, current ratio of 1.41, and stockholders' equity of $30.87B, with no disclosed debt-to-equity ratio suggesting minimal prior net debt. However, the July 2026 8-K discloses a $4.997B bond offering (floating rate + fixed tranches at 4.75%–5.60%, due 2029–2036) to fund $9B in FY26 M&A — this is a meaningful structural shift from a net-cash fortress to a levered acquirer. This is precisely the late-cycle, loose-money behavior I watch for: cheap-ish equity issuing expensive debt to buy high-growth (48% ARR) OT cyber assets at cycle-peak multiples. The margin of safety in the equity improves from the price decline, but the capital structure is deteriorating. The DCF intrinsic value rests on 4.19% FCF growth (revenue CAGR) and a 9.76% WACC — conservative assumptions, yet 71.7% of value sits in the terminal value, making it highly sensitive to whether Accenture sustains relevance through the AI transition. The crowd's first-level view is that AI disrupts Accenture; the second-level question is whether Accenture becomes the AI implementation layer for enterprises. That thesis is plausible (104 $100M+ bookings, per narrative) but unproven and not yet visible in revenue acceleration. The sentiment picture is mixed-to-tactical rather than full capitulation — retail shows relief-rally interest, not revulsion; institutional commentary is sparse. This is not yet the 'blood in the streets' moment that commands full conviction, but neither is it a crowded consensus long. The dividend (raised 10% to $1.63/quarter) and $9.5B+ planned shareholder returns provide partial downside cushion. My concern: $9B M&A funded partly by ~$5B in new bonds at 4.75–5.60% rates while organic growth decelerates to 3–4% LCY is precisely the kind of financial engineering that can turn a quality franchise into a leveraged bet on integration success. If Dragos/RunZero/NetRise integration disappoints and macro softens, the combined FCF may need to service meaningfully more debt while organic revenue growth stays subdued — eroding the margin of safety. The bear case DCF at $224 still exceeds current price, which is reassuring, but that assumes no FCF deterioration from M&A drag or integration costs. Overall: the price has moved meaningfully toward value and the worst sentiment is partially reflected, but the capital structure shift and M&A execution risk prevent a full 'pass' verdict. A 'watch' at current prices, with a better entry point possible if the stock retests lows or if M&A concerns crystallize further.

Key points

• Price is 37% below 52-week high and 25% below 1-year ago price, representing meaningful sentiment-driven compression from peak popularity
• DCF base intrinsic value ~$274/share vs $183 current price (49% upside per valuation block); even bear case $224 exceeds market price, suggesting partial margin of safety
• FCF quality is high: $10.87B FY2025 FCF (10-K 2025-10-10), FCF/net income ~1.42, capex only $600M — genuinely asset-light
• Balance sheet held net cash pre-July 2026; current ratio 1.41, $9.65B cash as of most recent period
• Dividend raised 10% to $1.63/quarter; $9.5B+ FY26 shareholder returns provide downside cushion and management capital discipline signal
• Operating margin expanded 20bps to 17% in Q3 FY26 (narrative); 8 consecutive quarters of expansion is real operational leverage
• Second-level question is interesting: market prices consulting disruption, but Accenture may be the AI implementation layer — 104 $100M+ bookings YTD cited in narrative
• Sentiment is tactical relief, not full capitulation — not yet maximum pessimism that commands highest conviction entry

Red flags

• July 2026 8-K: $4.997B bond offering at 4.75–5.60% rates to fund $9B FY26 M&A — structural shift from net-cash to levered acquirer is a red flag for a decelerating-growth business
• $9B M&A (Dragos, RunZero, NetRise, others) at peak OT-cyber valuations (48% ARR growth assets command high multiples) with no disclosed profitability targets or integration margin guidance — buying high-growth assets with expensive debt is late-cycle behavior
• 71.7% of DCF value sits in terminal value — highly sensitive to long-run relevance of consulting model in AI era; this is not a conservative valuation anchor
• Organic revenue growth decelerated to 3% LCY in FY26 while M&A spend accelerates — masks whether the core franchise is growing or being maintained through acquisition
• AI bookings segmentation stopped after Q1 FY26 (per narrative); management no longer discloses AI revenue/bookings breakdown, reducing transparency precisely when it matters most
• Business optimization costs ($615M in FY2025 per 10-K, $308M in first nine months of FY26 per 10-Q) are recurring; labeling as non-GAAP adjustments risks understating true earnings drag
• FY27 guided 3–6% LCY growth (narrative) implies minimal EPS acceleration even with $9B inorganic contribution — dead-money risk if integration stumbles

Ray Dalio — 🟡 watch · 52/100 · medium confidence

Accenture is a large, globally diversified professional services firm with genuinely strong free cash flow and a light physical capital base — but from a Dalio macro lens it carries several regime vulnerabilities that prevent a clean pass. On the positive side: the business is geographically diversified (Americas, EMEA, Asia-Pacific), generates real FCF ($10.87B in FY2025, 15.6% margin per fundamentals), has virtually no net debt ($9.6B cash vs. newly issued ~$5B in long-term notes per the July 2026 8-K), and its managed-services revenue has some sticky, contractual character. The current-ratio of 1.41x and ROE of 24.9% (fundamentals) signal operational quality. However, Accenture's core consulting demand is deeply pro-cyclical and discretionary — exactly the spending enterprises cut first in a downturn or credit contraction. The company itself acknowledged that 'longer decision-making' in EMEA and macro uncertainty compressed the Q4 guidance range to 1-5% LCY (narrative), a wide band that signals low visibility. The $9B FY26 M&A program (Dragos, RunZero, NetRise, Alpha Health, Whaler per narrative) has been partly financed by a $4.979B debt offering (8-K filed July 10, 2026), introducing ~$5B in new long-term fixed-rate notes (4.75% to 5.60% coupons, 2029-2036 maturities). This is manageable given the FCF base but marks a meaningful shift from the previously near-zero net-debt posture. The debt is fixed-rate and long-dated (2029-2036), which is structurally sound and mitigates short-term refinancing risk — but interest coverage deteriorates if FCF contracts in a downturn and the coupon burden is now real. On regime robustness: ACN wins in rising-growth/low-inflation (boom) — clients invest in transformation. It partially survives rising-growth/rising-inflation if it can pass through wage inflation (pricing power is moderate; R&D costs fell from $1.15B in FY24 to $817M in FY25 per 10-K, suggesting cost flexibility). It suffers in stagflation (clients freeze discretionary IT spend while ACN's own labor costs rise — the $615M business optimization charge in Q4 FY25 including $344M employee severance per 10-K is evidence management sees this threat). It suffers in deflationary bust (enterprise IT budgets collapse, managed services deals push out as happened per narrative). So ACN passes in roughly one strong and one partial regime out of four — below Dalio's all-weather bar. The labor model is intrinsically inflationary (350,000+ knowledge workers; wage inflation is the primary cost), and Accenture's pricing power to offset this is constrained by competitive intensity and multi-year contract structures. The intangible-asset amortization line rising from $530M in FY24 to $746M in FY25 (10-K) reflects acquisition pace and will continue upward with $9B FY26 M&A — compressing reported margins even if cash earnings hold. The stock's beta of 1.09 (fundamentals) confirms high correlation to broad equities — it adds beta, not diversification, to a typical equity book. The DCF intrinsic value of $274/share vs. $183 current price (49.5% upside per valuation block) is real margin of safety, and the bear-case DCF of $224 still shows upside from current levels, which provides partial cushion against regime-shift re-rating. The 3-year revenue CAGR of only 4.2% (fundamentals) and FY27 guidance of 3-6% LCY (narrative) are unimpressive organically. AI disruption risk is genuinely two-sided: AI could automate large swaths of what Accenture charges for (code generation, testing, IT migration work) compressing revenue per engagement, OR Accenture could capture AI integration spend. The $9B M&A into OT cybersecurity and mid-market (Accenture Edge) is management's answer, but these are unproven at scale (narrative explicitly notes no revenue targets or margin guidance for Edge). Net assessment: this is a quality business with a stressed regime profile, newly elevated (though manageable) debt, high equity correlation, moderate inflation pass-through risk, and discretionary demand vulnerability. Score 52 — watch, not pass, not avoid.

Key points

• Geographic revenue diversification (Americas, EMEA, Asia-Pacific) provides partial macro hedge across currency and economic cycles
• FY2025 FCF of $10.87B (15.6% margin) and $9.65B cash (fundamentals) give strong self-funding capacity for near-term stress
• New $4.979B debt issuance (8-K July 10, 2026) is fixed-rate, long-dated (2029-2036 maturities at 4.75-5.60%), limiting short-term refinancing risk
• Operating margin expanded 20bps to ~17% (Q3 FY26, narrative); 8 consecutive quarters of expansion demonstrates cost discipline
• DCF intrinsic value $274/share vs. $183 price (49.5% upside); even bear-case $224 is above current price — meaningful margin of safety
• Managed-services revenue (+5% LCY Q3 FY26 per narrative) is stickier/contractual vs. consulting, providing partial downside buffer

Red flags

• Consulting demand is discretionary and highly pro-cyclical — management's own Q4 guidance range (1-5% LCY) signals low macro visibility in any slowdown regime
• Labor cost inflation risk: primary input is knowledge workers; $615M business optimization charge in Q4 FY25 (including $344M employee severance per 10-K FY2025) reveals margin fragility when revenue slows
• $9B FY26 M&A funded partly with ~$5B new debt shifts balance sheet from net-cash simplicity toward moderate leverage; integration risk unquantified (no profitability targets disclosed per narrative)
• Beta 1.09 (fundamentals) means high correlation to broad equities — adds beta not diversification to a typical portfolio, violating Dalio's Holy Grail criterion
• Intangible asset amortization rose from $530M (FY24) to $746M (FY25) per 10-K and will continue rising with M&A pace, masking true FCF conversion quality
• AI disruption is genuinely two-sided: automation of code, testing, and IT migration work could compress revenue per engagement; management thesis unproven at scale with no segment-level AI margin data disclosed (narrative)

AI & Disruption Referee (Christensen-style) — 🟡 watch · 52/100 · medium confidence

Accenture presents the most complex and genuinely ambiguous case in the AI disruption framework: it is simultaneously one of the most AI-threatened business models (large-scale human expertise/labor intermediary) and one of the most credible incumbent adapters. The core disruption question is stark — Accenture's fundamental unit of value is deploying skilled human labor (consultants, developers, analysts, architects) to solve enterprise problems. This is precisely the category of knowledge work that frontier LLMs are automating most aggressively. A Christensen analysis demands we ask: can AI do the same job cheaper/faster and remove the need for Accenture? The answer is 'partially yes and accelerating' — but the failure mode is slower and more complex than classic disintermediation because Accenture's moat is not purely algorithmic matching but embedded multi-year client relationships, implementation accountability, regulatory navigation, and organizational change management. The bull case is that Accenture becomes the AI implementation layer for the Fortune 500 — the entity that deploys AI at scale for clients who cannot do it themselves. The bear case is that as AI tools become powerful enough, large enterprises build internal AI capability (in-housing), hyperscalers bundle implementation services, and AI-native boutiques undercut Accenture's billable-hour economics. Both are plausible 3-10 year scenarios. The evidence base shows genuine ambiguity: 104 $100M+ AI bookings YTD (per narrative, Q3 FY26 earnings) signals real enterprise demand routing through Accenture, but management stopped disclosing AI bookings/revenue after Q1 FY26 (per narrative caveats), which is an honesty red flag that prevents confident verification. The $9B M&A spend on OT cybersecurity (Dragos, RunZero, NetRise per 8-K filed 2026-06-18 and narrative) signals management knows the legacy consulting TAM is constrained and is buying adjacencies — a rational move but also a tacit admission that organic consulting alone faces structural headwinds. Revenue CAGR of 4.2% over 3 years (fundamentals block) is modest for a company claiming AI tailwinds; if AI were a genuine accelerant, we would expect faster growth, not deceleration to 3-4% LCY guidance (per FY26 guidance in narrative). The unit economics threat is the most important signal: if AI automates junior consultant work (coding, analysis, deck production), Accenture faces a pyramid compression problem — either it earns less revenue per engagement (pricing pressure) or it needs far fewer people per project (margin expansion only if it captures the efficiency). The 10-K (filed 2025-10-10) records $615M in business optimization costs including $344M employee severance for 'headcount reductions in a compressed timeline' and cites 'identifying areas to drive even more operating efficiencies in our business, including through AI' — this is management acknowledging AI is automating their own workforce. This is both a cost tailwind and a warning that the revenue model built on headcount is under structural pressure. Operating margin of 14.68% (fundamentals) and 17% in Q3 FY26 (narrative) expanding at 20bps/year is consistent with AI-driven efficiency gains flowing to margins — but it could also be the early phase of the melting ice cube where efficiency gains mask slower volume growth. The hyperscaler bundling risk is real: Microsoft (via Avanade JV, referenced in narrative re: Accenture Edge launch), Google, and Amazon all have professional services arms and are aggressively packaging implementation consulting into cloud deals. OpenAI's enterprise partnerships could disintermediate Accenture's AI transformation advisory work if the AI vendor provides implementation directly. The Accenture Edge launch targeting mid-market ($240B TAM per narrative) is a strategic response, but the mid-market is exactly where AI-native, lower-cost competitors have the most structural advantage over a high-overhead incumbent. The falsifiable signals to watch: (1) if take-rates or revenue per consultant-equivalent fall while headcount shrinks faster than revenue grows, commoditization is winning; (2) if AI bookings (when/if re-disclosed) accelerate and $100M+ program count grows >20% annually, Accenture is capturing the AI integrator premium; (3) if hyperscalers begin explicitly bundling implementation into cloud contracts at discounted rates, the toll disappears. Management's honesty score is mixed — Julie Sweet's framing of 'green shoots' and 104 $100M+ bookings is constructive but the cessation of AI segmentation (per caveats) is a transparency failure. The $9B M&A pivot acknowledges the core model needs augmentation. Overall: not an avoid because the adaptation is genuine and the client relationships are stickier than simple matching intermediaries, but not a pass because the structural threat to the billable-hour model is real, organic growth is decelerating, and the AI-accelerant thesis lacks verifiable data.

Key points

• Core business (human expertise deployment) is exactly what LLMs automate — junior analyst, developer, and advisory tasks are AI's fastest-advancing frontier, creating structural headcount pressure (10-K FY25 confirms $344M severance for compressed-timeline reductions citing AI efficiency)
• Management acknowledges AI is automating their own workforce (10-K 2025-10-10: 'drive operating efficiencies through AI') — a dual signal: cost tailwind but also implicit admission the revenue-per-human model is under stress
• 104 $100M+ AI bookings YTD (+13% vs FY25, per Q3 FY26 narrative) is the strongest bull evidence — suggests enterprises are paying Accenture to implement AI, not bypassing it; this is the critical falsifiable data point to track
• Revenue CAGR of 4.19% over 3 years (fundamentals) and FY26 guidance of 3-4% LCY growth is inconsistent with a company riding a genuine AI demand wave — if AI were a net accelerant, organic growth should be accelerating not decelerating
• $9B FY26 M&A spend (Dragos, RunZero, NetRise OT cyber per 8-K 2026-06-18; Alpha Health, Accenture Edge per narrative) is a strategic pivot away from pure consulting — management implicitly acknowledges legacy TAM is constrained and is buying platform/recurring-revenue exposure
• Hyperscaler bundling risk: Microsoft (Avanade JV), Google, and Amazon have both the AI models AND professional services distribution; if they bundle implementation into cloud deals, Accenture's consulting toll compresses
• AI segmentation opacity: stopped disclosing AI bookings after Q1 FY26 (per narrative caveats) — this is an honesty red flag; without segment data, it is impossible to verify whether AI is net tailwind or net headwind on margins and growth
• FCF margin of 15.61% (FY25) and operating margin expansion (+20bps) could reflect genuine AI productivity gains OR the early harvest of a model that is retracting — distinguishing these requires granular data not available in the fact base

Red flags

• Revenue is structurally tied to billable human hours — the exact unit AI is deflating in price; any sustained AI coding/analysis capability improvement directly compresses Accenture's revenue-per-engagement without offsetting volume growth
• Management stopped disclosing AI bookings/revenue breakdown after Q1 FY26 (per narrative), precisely when the market most needs to verify the AI-enabler thesis — creates information asymmetry and raises credibility concerns
• $9B M&A in one year (vs prior $5B guidance, per narrative) is a panic-buying signal of adjacencies; integration risk on Dragos/RunZero/NetRise is unproven and Truist cut PT post-Q3 suggesting sell-side skepticism on execution (per narrative)
• Consulting revenue growth at only +1% LCY in Q3 FY26 (per narrative) — the highest-margin, highest-expertise service line is stagnating, consistent with clients either in-housing AI capability or deferring discretionary transformation spend
• Mid-market (Accenture Edge) entry targets the segment most vulnerable to AI-native, low-cost competition; no revenue, margin, or customer-acquisition data disclosed (per narrative caveats) — high risk, unproven
• Accenture's own headcount optimization ($344M severance, 10-K 2025-10-10) signals the business model is shrinking its human capital base — if AI enables fewer people to do the same work, the revenue model built on staffing scale faces secular compression unless pricing per engagement rises commensurately, which is not evidenced

Stanley Druckenmiller — 🟡 watch · 52/100 · medium confidence

Accenture presents a genuinely mixed picture through the Druckenmiller lens. The forward earnings direction is the critical question, and the answer is equivocal. On the positive side: FY25 FCF inflected sharply upward to $10.87B (vs $8.61B in FY24, per fundamentals block), EPS grew 9% in Q3 FY26 on only 3% revenue growth — showing real operating leverage — margin expanded 20bps to 17%, and management guided $13.78–$13.90 EPS for FY26 (+7-8%). Bookings came in at $22.2B vs $19.9B expected in Q4 FY26 (per narrative), suggesting the demand pipeline is not collapsing. The DCF (10-K filed 2025-10-10, confirmed in valuation block) shows intrinsic value of ~$274 vs current price of $183 — a 49.5% discount — which is a meaningful margin of safety even under the bear case ($224). The dividend was raised 10% to $1.63/quarter (per narrative), signaling management confidence.

However, several Druckenmiller-style disqualifiers temper enthusiasm significantly. TAPE IS THE MOST SERIOUS PROBLEM: ACN is down ~37% from its 52-week high of $291.09 and down ~25% over the past year (price block). This is a stock in a clear downtrend, trading at $183 — well below the 52-week high. The Druckenmiller discipline is unambiguous: don't size up when the tape is breaking down, even if the fundamental story is compelling. The price action is telling a different story than management's AI-optimism narrative. Second, the EARNINGS DIRECTION IS DECELERATING, not accelerating: revenue CAGR over 3 years is only 4.19% (fundamentals block), FY26 guidance is 3-4% LCY growth (narrative), and FY27 guidance of 3-6% LCY implies further deceleration from historical 5-7%. The second derivative is turning negative, which is exactly what Druckenmiller penalizes. Third, $9B of M&A spend in FY26 (Dragos, RunZero, NetRise per narrative; debt issuance of ~$5B per 8-K filed 2026-07-10) is adding balance sheet complexity and integration risk precisely when the business itself faces macro headwinds — this muddies the earnings trajectory that a clean directional bet requires. The July 2026 debt issuance ($4.979B net proceeds across floating rate and fixed notes at 4.75-5.60%, per 8-K filed 2026-07-10) means Accenture has added meaningful leverage into a still-elevated rate environment. Fourth, the CATALYST TIMING IS UNCLEAR: AI revenue stopped being disclosed as a separate metric after Q1 FY26 (per narrative caveats), which removes a key data point for judging whether the AI inflection thesis is validating. You cannot manage a concentrated position when the key KPI goes dark. Fifth, consulting — the higher-margin and historically faster-growing segment — is only growing 1% LCY in Q3 FY26, with recovery to 'low single digits' full year. This is not an inflecting business in the Druckenmiller sense.

On AI disruption: This is existential to the Accenture thesis and cuts both ways. The bull case is that Accenture IS the AI implementer — it benefits from the enterprise AI capex wave. The bear case is that AI commoditizes consulting labor (Accenture's cost structure is ~70%+ human capital), and agentic AI threatens to disintermediate the IT staffing and traditional systems integration work that remains Accenture's bread and butter. The $615M in 'business optimization costs' in Q4 FY25 (10-K filed 2025-10-10) — including $344M in employee severance for 'headcount reductions in a compressed timeline' — is management itself signaling the labor model is being restructured. This is either a positive (AI-driven margin expansion) or negative (business model under pressure); the answer is unknowable over a 12-18 month horizon with the data available. For Druckenmiller's concentrated-bet framework, this uncertainty is disqualifying at size.

The macro/liquidity backdrop is not clearly a tailwind. The floating rate note issued (8-K filed 2026-07-10) alongside fixed-rate debt at 4.75-5.60% suggests Accenture is paying up for capital. Real rates remain elevated enough that the multiple compression risk on a large-cap growth consultancy is not gone. No clear Fed easing catalyst is identified in the fact base that would serve as a liquidity tailwind to reprice this stock.

Bottom line: The stock may be a good long-term value, but the Druckenmiller framework requires the tape to confirm, the earnings direction to be clearly inflecting up, and a catalyst to be identifiable. None of these three conditions are cleanly met today. The stock is a watch — worth tracking for a setup where price action reverses (confirmation of a bottom), AI revenue disclosure resumes (evidence of inflection), or consulting bookings accelerate materially. Not a position to size up into now.

Key points

• FCF inflected sharply: $10.87B in FY25 vs $8.61B in FY24, FCF margin recovered to 15.6% — positive second derivative on cash generation (fundamentals block)
• Q3 FY26 EPS +9% on +3% revenue shows meaningful operating leverage; 8 consecutive quarters of margin expansion (narrative)
• Q4 FY26 bookings $22.2B vs $19.9B expected — pipeline signal is healthy (narrative)
• DCF intrinsic value $274 vs $183 current price (49.5% upside); even bear case $224 is well above current price (valuation block)
• $9B M&A spend in FY26 targeting OT cybersecurity (Dragos: $208M ARR, 48% growth) and mid-market ($240B TAM) — inorganic growth vectors identified (narrative)
• Dividend raised 10% to $1.63/quarter; $9.5B+ shareholder returns guided for FY26 (narrative)

Red flags

• TAPE IS BROKEN: ACN -37% from 52-week high of $291.09, -25% over trailing year — price action disagrees with the bull thesis, violating core Druckenmiller discipline (price block)
• Revenue growth decelerating: 3-year CAGR 4.19%, FY26 guided 3-4% LCY, FY27 guided 3-6% — second derivative is negative (fundamentals block, narrative)
• $4.979B net debt issuance at 4.75-5.60% in July 2026 adds leverage in elevated rate environment; floating rate tranche adds interest cost sensitivity (8-K filed 2026-07-10)
• AI revenue KPI removed after Q1 FY26 — key tracking metric for the thesis went dark, making position management impossible (narrative caveats)
• $615M in Q4 FY25 business optimization costs including $344M severance signals structural labor model disruption — either positive (AI productivity) or negative (business under pressure), but unresolvable in 12-18 month horizon (10-K filed 2025-10-10)
• Consulting growth only +1% LCY in Q3 FY26 — the higher-margin segment is not inflecting (narrative)
• No identifiable Fed/liquidity catalyst visible in the fact base to reprice the multiple; macro tailwind absent
• M&A integration risk on three OT cyber assets simultaneously ($9B total spend) muddies earnings trajectory needed for clean directional bet (narrative)

Benjamin Graham — 🟡 watch · 52/100 · high confidence

Accenture is a large, established, profitable enterprise with an unbroken earnings and dividend record — precisely the kind of business Graham respected. However, it fails several of his quantitative safety tests decisively, and the current price, while well off its 52-week high, does not offer the margin of safety Graham required. Working through the tests systematically: (1) EARNINGS STABILITY: Positive every year in the five-year history provided (fundamentals block), with net income rising from $5.9B in 2021 to $7.7B in 2025 — well over Graham's one-third growth threshold. Diluted EPS of $12.15 in FY2025 vs. $11.44 in FY2024 per the 10-K filed 2025-10-10. Full ten-year data is not in the fact base, but no loss years are visible. PASS. (2) DIVIDEND RELIABILITY: Dividend raised 10% to $1.63/quarter (narrative); uninterrupted record implied. PASS. (3) P/E: At $183.37 and trailing EPS ~$12.15 (10-K), trailing P/E is approximately 15.1x — right at Graham's defensive cap of 15x. Marginal pass, but barely. The fact base also quotes P/E of 14.61, which implies a very slight margin. BORDERLINE PASS. (4) P/B: Price-to-book of 3.64 (fundamentals block). Graham's combined rule is P/E × P/B ≤ 22.5. At 14.61 × 3.64 ≈ 53 — more than double the threshold. FAIL. (5) BALANCE SHEET — CURRENT RATIO: Current ratio 1.41 (fundamentals block, period 2025-11-30: current assets $28.1B, current liabilities $19.9B). Graham required at least 2.0 for defensive investors. FAIL. (6) DEBT vs. WORKING CAPITAL: Working capital = $28.1B - $19.9B = ~$8.2B. The July 2026 debt issuance (8-K filed 2026-07-10) added ~$5.0B in long-term senior notes at rates 4.75%–5.60%, in addition to pre-existing debt. The fact base notes debt_to_equity as null, but the new issuance alone is ~$5B versus ~$8.2B working capital. Long-term debt appears to exceed working capital, a Graham red flag. FAIL. (7) NET-NET: Not remotely applicable. Current assets of $28.1B vs. total assets of $64.7B; total liabilities imply stockholders' equity of $30.9B (fundamentals) meaning total liabilities ≈ $33.8B — vastly exceeding current assets. Net current asset value is deeply negative on a total-liability basis. (8) MARGIN OF SAFETY vs. DCF: The DCF intrinsic value of $274/share (valuation block) implies 49.5% upside. At first glance this suggests a margin of safety, but Graham was deeply skeptical of DCF projections; the terminal value represents 71.7% of enterprise value (valuation block), making the estimate highly sensitive to assumptions about perpetual growth — exactly the kind of speculative projection Graham distrusted. His preference was for conservatively estimated asset or earnings value, not optimistic discounted growth. I treat the DCF as directionally helpful but not as a reliable Graham margin-of-safety signal given terminal value dominance. (9) AI/DISRUPTION RISK: This is material to a Graham assessment because it bears on earnings stability. The narrative acknowledges that Accenture stopped breaking out AI bookings after Q1 FY26, and that consulting growth (1% LCY in Q3) is decelerating. Management is spending $9B on acquisitions to reposition into OT cybersecurity and mid-market segments (narrative). If AI automates a material portion of consulting work, the earnings base that supports current valuation could erode. Graham would demand a larger margin of safety to compensate for this structural uncertainty — the opposite of what the current price provides. The $615M business optimization charge in FY2025 (10-K filed 2025-10-10, including $344M severance and $271M asset impairments) signals that some talent/asset write-down has already begun. SUMMARY: Accenture is a quality enterprise with stable earnings and dividends, but it is not a Graham value stock at current prices. The P/B of 3.64, the P/E × P/B product of ~53, the current ratio of 1.41, the new debt load that strains working capital headroom, and the total absence of any net-net characteristic all place it outside Graham's quantitative safety zone. The only near-qualifying feature is the P/E hovering just below 15x. The stock is 37% off its 52-week high, which is psychologically attractive but does not by itself create intrinsic value. I score this 52: a 'watch' — not a buy for Graham purposes, but not an avoid, given earnings stability and the meaningful (if DCF-dependent) valuation discount. A further 20–25% price decline, with no deterioration in earnings, would begin to approach Graham territory.

Key points

• Trailing P/E ~14.6x (fundamentals) is at Graham's 15x defensive ceiling — borderline acceptable on earnings alone
• Five-year earnings history shows uninterrupted profitability and meaningful growth (net income $5.9B→$7.7B, 2021–2025 per fundamentals block)
• Dividend raised 10% to $1.63/quarter (narrative); uninterrupted record implies reliability test passed
• DCF intrinsic value of $274/share (valuation block) implies ~50% upside, but terminal value is 71.7% of EV — Graham would discount this heavily as speculative
• Business optimization charge of $615M in FY2025 (10-K filed 2025-10-10) includes $344M severance + $271M asset impairments, signaling structural repositioning cost

Red flags

• P/B of 3.64 × P/E of 14.61 = ~53, more than double Graham's combined limit of 22.5 (fundamentals block)
• Current ratio of only 1.41 (fundamentals block, period 2025-11-30) — well below Graham's minimum of 2.0
• July 2026 debt issuance of ~$5.0B in senior notes (8-K filed 2026-07-10) at 4.75%–5.60% pushes long-term debt toward or beyond working capital of ~$8.2B
• Net-net test fails entirely: total liabilities of ~$33.8B (implied from equity of $30.9B vs. assets of $64.7B) vastly exceed current assets of $28.1B
• AI/automation disruption is a material earnings-stability risk: consulting revenue growing only 1% LCY in Q3 FY26 (narrative), and Accenture has ceased disclosing AI bookings breakdown — opacity that Graham would penalize
• $9B acquisition program in FY2026 (narrative) with no disclosed profitability targets or margin accretion timeline; goodwill accumulation risk not quantifiable from this fact base

Joel Greenblatt — 🟡 watch · 52/100 · medium confidence

Accenture is a high-quality, capital-light professional services business that scores well on the ROIC axis of the Magic Formula but comes up short on the earnings yield axis at current prices — even after a 37% drawdown from the 52-week high. Let me work through the two formula inputs from the filings.

ROIC (Greenblatt's denominator: net working capital + net fixed assets): From the 10-K filed 2025-10-10 (FY2025, period ending Aug 31, 2025) and the 10-Q filed 2026-06-18 (period ending May 31, 2026): Current assets $28.1B, current liabilities $19.9B → net working capital ~$8.2B. Net PP&E from the 2024 10-K was ~$1.5B; the 2025 10-K does not give a discrete net PP&E figure in the excerpts but depreciation of $622M on modest capex of $600M (fundamentals block, FY2025) suggests a similar or slightly lower figure — call it roughly $1.4-1.6B. Tangible capital employed ≈ $9.6-9.8B. EBIT for FY2025 is $10.2B (operating income per fundamentals block). Greenblatt ROIC = $10.2B / ~$9.7B ≈ 105%. This is exceptional — Accenture earns more EBIT than its entire tangible capital base in a year, a hallmark of a truly capital-light, high-return business. No red flag here; this is among the best ROIC profiles imaginable.

Earnings Yield (Greenblatt's numerator: EBIT / EV): EV = market cap + total debt + minority interest - excess cash. Market cap = $112.2B (fundamentals). Debt: The July 2026 8-K discloses a ~$5B debt issuance (notes due 2029-2036); prior to this, the 10-K (FY2025) notes interest expense of $229M suggesting meaningful existing debt. The 2025 10-K references increased long-term debt as reason for interest expense growth. Using the $5B July issuance plus prior debt (estimated ~$1-2B from interest expense run-rate at prior low levels), total debt is roughly $6-7B post-July 2026. Cash = $9.6B (fundamentals, Nov 2025 period). Net cash position is approximately neutral to slightly net debt after the July 2026 bond issuance. Minority interest is modest. EV ≈ $112B + $6.5B - $9.6B ≈ $109B (rough). EBIT = $10.2B (FY2025). Earnings yield = $10.2B / $109B ≈ 9.4%. That is a respectable but not Magic Formula-tier earnings yield. Greenblatt's formula historically favors yields above 10-15% to rank near the top of a 3,500-stock universe. At 9.4%, Accenture would rank in the middle of the distribution — decent but not a screaming bargain on this axis. Note the DCF (valuation block) shows 49.5% upside to intrinsic value of $274/share, suggesting the market is discounting the business more than fair — but the earnings yield as I calculate it is middling, not cheap.

Magic Formula combined ranking: ROIC is top decile globally. Earnings yield is middle-of-pack. The combination is 'above average business at a fair price' — not the ideal Magic Formula sweet spot of 'above average business at a below-average price.' The stock would score well on quality but only modestly on cheapness.

Cash conversion and earnings quality: FCF of $10.9B vs. operating income of $10.2B (FY2025 per fundamentals) is actually slightly above EBIT — strong conversion. FCF margin of 15.6% is healthy and stable across the 5-year history (16.6% in 2021, 15.6% in 2025). Business optimization charges ($615M in Q4 FY2025, $308M in first half FY2026 per 10-Q filed 2026-06-18) are recurring-ish restructuring costs that inflate reported EBIT somewhat; adjusting for these on a normalized basis (say $300-400M/year run-rate) would reduce EBIT to ~$9.8-9.9B — not material to the thesis.

Special situation angle: None present. This is a large-cap index constituent, heavily covered, no spinoff, restructuring catalyst, or institutional neglect dynamic that Greenblatt's special-situations playbook would exploit.

AI disruption through the value lens: Accenture's ROIC is so high precisely because it employs minimal tangible capital — it sells human expertise. If AI commoditizes that expertise (reducing billing rates, headcount, or contract scope), the revenue and margin base compress. Management is explicitly repositioning toward AI enablement and has spent $9B on M&A in FY26 (narrative), including OT cybersecurity (Dragos, $208M ARR growing 48%). The risk is that the M&A spend (goodwill-heavy, intangible-heavy) inflates invested capital while returns on the legacy consulting base erode. From a Greenblatt lens, this is a watch item: the current ROIC is pristine but could deteriorate if the capital base grows (via M&A goodwill) faster than EBIT. The $9B FY26 M&A spend is approximately equal to Accenture's entire current tangible capital base — this matters for future ROIC calculations.

Debt issuance: The July 2026 8-K shows ~$5B in new notes (4.75%-5.6% coupons, due 2029-2036) explicitly for M&A liquidity. This moves Accenture from a net cash position to a more balanced or slightly net debt position, modestly raising EV and thus modestly reducing earnings yield. Not a red flag given the FCF coverage, but worth noting.

Conclusion: Great business (top-decile ROIC), fair-to-reasonable price (middle-decile earnings yield ~9.4%), no special-situation catalyst, and meaningful M&A execution risk that could dilute future ROIC. Score of 52 (watch) reflects a stock that qualifies as a 'good business at a fair price' — Buffett's category, not Greenblatt's Magic Formula sweet spot. Worth monitoring for price weakness that would push earnings yield above 12-13% (stock price ~$140 or below), which would bring both axes into Magic Formula range simultaneously.

Key points

• ROIC (Greenblatt tangible capital method): EBIT $10.2B / tangible capital ~$9.7B ≈ 105% — exceptional, top decile globally; capital-light model with minimal fixed assets (capex $600M, net PP&E ~$1.5B per 2024 10-K) and modest net working capital (~$8.2B from Nov 2025 balance sheet in fundamentals)
• Earnings yield: EBIT ~$10.2B / EV ~$109B (market cap $112B + ~$6.5B debt post-July 2026 issuance per 8-K filed 2026-07-10 - $9.6B cash) ≈ 9.4% — respectable but below the 12-15%+ threshold Greenblatt's formula favors for top rankings
• FCF conversion is strong: $10.9B FCF vs. $10.2B EBIT in FY2025 (fundamentals block); FCF margin stable at 15-16% over 5-year history — earnings are real and cash-backed
• No special-situation catalyst: large-cap, heavily covered, no spinoff or restructuring creating institutional neglect or forced selling
• $9B FY2026 M&A spend (narrative: Dragos, RunZero, NetRise, Alpha Health) is roughly equal to entire current tangible capital base — future ROIC calculations will include significant goodwill/intangibles, potentially diluting the metric that makes this business attractive
• DCF intrinsic value $274/share vs. $183 current price implies 49.5% upside (valuation block) — meaningful margin of safety on absolute basis even if not Magic Formula cheap on earnings yield alone

Red flags

• Single-axis strength: ROIC is exceptional but earnings yield (~9.4%) is middle-of-pack, not the Magic Formula dual-axis bargain Greenblatt requires — 'good business at fair price' rather than 'good business at cheap price'
• $9B FY26 M&A (8-K filed 2026-07-10 plus narrative) will load the balance sheet with goodwill and intangibles, potentially inflating future invested capital and compressing ROIC — the metric that justifies the quality premium
• July 2026 debt issuance of ~$5B (8-K filed 2026-07-10: floating rate + fixed notes at 4.75%-5.6%) shifts Accenture from net cash to roughly net debt position, modestly raising EV and reducing earnings yield
• Recurring restructuring charges ($615M in Q4 FY2025 per 10-K filed 2025-10-10; $308M in first nine months FY2026 per 10-Q filed 2026-06-18) suggest normalized EBIT is somewhat below reported figures — three consecutive years of 'business optimization' costs is a pattern, not a one-off
• AI disruption risk is material to the ROIC thesis: if AI commoditizes consulting deliverables, billing rates compress and headcount falls, shrinking the revenue and EBIT base that currently generates the exceptional returns on minimal tangible capital
• No insider ownership signal or management alignment mechanism visible in filings that would serve as a special-situation catalyst for discount closure

Seth Klarman — 🟡 watch · 52/100 · medium confidence

Accenture presents a genuinely interesting value question post a ~37% decline from its 52-week high and ~25% decline over the past year. The stock trades at $183.37 against a DCF intrinsic value of $274.14, implying roughly 49% upside on the base case. However, from my perspective, this is not a classic margin-of-safety situation. Let me work through the downside case first.

Balance sheet: As of the most recent filings (10-Q filed 2026-06-18, period ending May 31, 2026), cash and equivalents stand at $9.65B. The company raised approximately $5B in long-term debt via a July 2026 bond offering (8-K filed 2026-07-10) comprising notes due 2029-2036 at rates of 4.75%-5.60%. This is new, sizable leverage taken on to fund M&A ($9B targeted for FY26). Prior filings showed total lease liabilities of ~$3.03B (10-K 2025). Stockholders equity is $30.87B but goodwill from acquisitions is substantial — the 10-K (2025) notes $5.3B goodwill from FY24 acquisitions alone, with cumulative M&A spend rising sharply. A liquidation-value floor is weak here: the balance sheet is dominated by goodwill, intangibles, and service-contract receivables ($13.99B in receivables per the May 2026 10-Q), not hard assets. Property and equipment net was only ~$1.52B (10-K 2024). The 'asset backing' that Klarman-style analysis requires is thin.

Normalized cash flow: FCF for FY2025 was $10.87B (per fundamentals), and FCF yield at current price is 9.7% (price-to-FCF of 10.32). This is attractive on a going-concern basis. FCF has been consistently strong: $8.4B (FY21), $8.8B (FY22), $9.0B (FY23), $8.6B (FY24), $10.9B (FY25). The FY25 jump is partly explained by working capital timing; the multi-year average is ~$9-10B. At $112B market cap, that is roughly 11-12x normalized FCF — not expensive for a business of this quality, but not a screaming value either. It is a fair price for a good business.

Margin of safety stress test: The DCF relies on 4.19% FCF growth (revenue CAGR) and a 9.76% WACC with 2.5% terminal growth, producing $274 intrinsic value. In a bear scenario ($224), the stock at $183 is only modestly below the bear-case estimate — not a wide margin. If growth decelerates to 2% (management guiding 3-4% LCY for FY26, with FY27 guidance of only 3-6%), the terminal value shrinks materially. With 71.7% of DCF value in the terminal year (per valuation block), any downward revision to perpetuity growth assumptions dramatically impairs the 'intrinsic value.' A conservative Klarman stress test would use 1-2% perpetuity growth and a higher discount rate, which would push intrinsic value materially below the DCF base case.

New debt concerns: The $4.98B bond offering in July 2026 (8-K 2026-07-10) specifically to fund $9B in M&A (Dragos, RunZero, NetRise) introduces integration execution risk. Business optimization charges have been recurring: $615M in FY25 Q4, $438M in FY24, $1.06B in FY23 (10-K filings). These are not one-time items; they are a feature of managing a large professional services workforce through continuous restructuring. The $344M severance in FY25 plus $271M asset impairments (including divestiture of two acquisitions 'no longer aligned with strategic priorities') is a tell about M&A execution risk.

Catalyst analysis: There is no classic special-situation catalyst here. This is not a spin-off, liquidation, or forced-selling orphan. The price decline is partly macro/sector-driven (professional services/consulting rerating) and partly AI disruption anxiety. The 'catalyst' is management execution on AI monetization and M&A integration — which is a growth/operational bet, not a structural unlocking event that Baupost would lean on.

AI disruption as a value lens: The most serious Klarman-relevant risk is secular. If AI automates a material portion of consulting delivery (code generation, analysis, project management), the revenue per headcount and margin structure could compress. Management is spending aggressively on AI repositioning ($817M R&D in FY25, per 10-K) and making a bet that Accenture becomes the AI systems integrator rather than a victim. This is a plausible but unproven thesis. From a downside-protection standpoint, I cannot assign hard asset value to this repositioning bet. The 'moat' in professional services is relationships, reputation, and talent — all of which AI threatens to commoditize over a 5-10 year horizon.

What partially supports a 'watch': The stock has fallen to levels where FCF yield (~9.7%) and dividend yield (approaching 3.5% annualized with the 10% dividend increase) provide a reasonable floor. The company is operationally sound, generates real cash, has strong client diversification, and is not financially distressed. The price decline reflects genuine uncertainty, not necessarily fundamental deterioration. The DCF bear case of $224 provides some cushion even on conservative assumptions, but not the large, durable margin of safety I require before making a meaningful commitment.

Key points

• FCF yield of ~9.7% (price-to-FCF of 10.32) is attractive on a going-concern basis, with multi-year FCF averaging $8.8-10.9B annually (fundamentals data)
• Stock trades ~37% below 52-week high and ~33% below DCF base-case intrinsic value of $274.14, suggesting some margin but not a wide one by Baupost standards
• Balance sheet has real cash ($9.65B per May 2026 10-Q) but new ~$5B debt load from July 2026 bond offering (8-K 2026-07-10) for M&A narrows the net cash cushion
• Recurring business optimization charges ($1.06B FY23, $438M FY24, $615M FY25 per respective 10-Ks) indicate structural workforce/asset management costs that are not truly one-time
• Dividend raised 10% to $1.63/share quarterly (per narrative); with buyback program of $7.5B for FY26 (8-K 2026-06-23), shareholder return policy provides some downside support
• DCF terminal value represents 71.7% of total enterprise value — highly sensitive to perpetuity growth assumptions that may prove optimistic if AI disrupts consulting economics

Red flags

• No classic margin-of-safety catalyst: price recovery depends on growth execution (AI monetization, M&A integration), not a structural unlocking event
• Asset-backing is weak for liquidation analysis: balance sheet is goodwill/intangibles/receivables-heavy with minimal hard assets (~$1.5B net PP&E per 2024 10-K) against $112B market cap
• $9B FY26 M&A program (Dragos, RunZero, NetRise plus others) introduces integration risk; Truist cut PT post-Q3 (per narrative); two acquisitions were already divested as 'no longer aligned' per FY25 10-K
• AI secular disruption is a genuine, hard-to-quantify threat to consulting revenue per headcount — management's repositioning bet is plausible but unproven and cannot be stress-tested with hard numbers
• Accenture stopped disclosing AI bookings/revenue after Q1 FY26 (per narrative caveats) — reduced disclosure is an opacity red flag for a business where the growth thesis centers on AI
• FY27 revenue guidance of 3-6% LCY (per narrative) is below historical 5-7% pace; if M&A integration stumbles, organic deceleration could produce a multiple-compression + earnings disappointment double hit
• Business optimization charges have been recurring for 3+ years ($1.5B+ cumulative in FY23-24 program alone per 2024 10-K), suggesting ongoing structural cost pressure not reflected in normalized margin assumptions

Peter Lynch — 🟡 watch · 52/100 · high confidence

Accenture is a stalwart — a large, well-understood professional services and technology consulting firm generating ~$70B in revenue with durable but moderate growth. The story is explainable in one sentence: Accenture helps large enterprises design, build, and run their technology and business processes, and is now positioning as the dominant AI-implementation partner. The fundamentals are high quality — 26% ROIC (10-K 2025), 15.6% FCF margin, consistent free cash flow ($8.4–$10.9B over five years), and a strong balance sheet with $9.6B cash (10-Q filed 2026-06-18). However, judged against my PEG framework, ACN fails the core test badly. The reported PEG is 3.49 (fundamentals block), and even on generous assumptions it remains far above 1.0. P/E of 14.6x on ~4.2% revenue CAGR (3-year, fundamentals block) — and EPS growth of roughly 6–7% (FY26 guidance: 7–8% adjusted EPS growth per narrative) — gives a yield-adjusted PEG (adding ~3.5% dividend yield to 7% growth) of roughly 14.6/10.5 = ~1.4x, still well above my comfort zone of <=1.0. For a stalwart, I'd want to buy and take 30–50% gains; the DCF (intrinsic $274, ~50% upside) is plausible but requires sustained 4.2% FCF growth for five years — modest — and a 2.5% terminal rate that is achievable. The bear DCF is $224, still above current price, which is reassuring. However, several Lynch-style red flags are flashing. First, diworsification risk: $9B in FY26 M&A (Dragos, RunZero, NetRise, Alpha Health, Whaler per narrative), a massive step-up from prior years ($6.5B in FY24 total consideration per 10-K 2024-10-10), pivoting into OT cybersecurity — a new domain — and mid-market (Accenture Edge, launch stage, no revenue). This is textbook 'diworsification.' Second, earnings growth is decelerating organically: 3% local-currency revenue growth in Q3 FY26, with federal headwinds and EMEA macro drag; FY27 guidance is 3–6% LCY (narrative). For a stalwart already at 14x earnings, deceleration compresses the multiple further. Third, the $5B debt issuance (8-K July 2026) to fund M&A while simultaneously buying back $7.5B in shares (8-K June 2026) is financial engineering that obscures organic earnings quality — exactly the complexity I distrust. Fourth, AI revenue opacity: management stopped breaking out AI bookings after Q1 FY26 (narrative caveats), making the core growth thesis unverifiable. On the positive side: the business is highly understandable, generates copious cash, has no net debt (net cash position, valuation block: -$9.6B net debt), ROIC of 26% is excellent, operating margin expanded 20bps to 17% in Q3 FY26 (narrative), and the dividend was raised 10% (narrative). The stock is down 37% from its 52-week high (price block), which creates a stalwart entry opportunity — but only if growth re-accelerates. AI/disruption assessment: This is the central tension. Accenture could be either the biggest winner (as the firm that implements AI for every Fortune 500 client) or a victim (if AI automates consulting work and reduces billable hours). The 104 $100M+ AI bookings YTD (+13% YoY, narrative) and managed services growth (+5% LCY) suggest the former is occurring. However, the consulting segment (+1% LCY in Q3) is the vulnerable flank — if AI reduces the labor-intensity of transformation projects, revenue per engagement shrinks. I cannot verify the net effect from this fact base. Verdict: ACN is a high-quality stalwart priced at a PEG too high for a Lynch 'buy,' with diworsification risk from aggressive M&A, and decelerating organic growth. It is not an avoid — the balance sheet is solid and the AI-enabler thesis is credible — but it is a watch until either (a) the PEG compresses to ~1.0x (EPS of ~$18+ at current price, or stock at ~$130–$140), or (b) M&A accretion and AI revenue acceleration demonstrably re-rate the growth to 12–15% sustained EPS, which would justify current price as a stalwart.

Key points

• Stalwart classification: ~$70B revenue, 4.2% 3-year revenue CAGR, 7-8% adj. EPS growth guide for FY26 (narrative) — fits stalwart, not fast grower
• PEG of 3.49 (fundamentals block) is far above my <=1.0 threshold; even yield-adjusted (~1.4x) remains unattractive for a stalwart
• FCF is exceptional: $10.9B in FY25 (fundamentals), 15.6% FCF margin, net cash position of $9.6B (valuation block assumptions)
• ROIC 26%, ROE 25% (fundamentals) — underlying business economics are elite
• DCF shows ~50% upside to $274 (valuation block) — downside protected even in bear case ($224 vs $183 current price)
• Dividend raised 10% to $1.63/quarter (narrative); $7.5B buyback authorized FY26 (8-K June 2026) — shareholder returns robust
• Operating margin 17% in Q3 FY26, expanded 20bps (narrative); 8 consecutive quarters of expansion cited
• 104 $100M+ AI bookings YTD, +13% vs FY25 (narrative) — AI implementation thesis has early traction

Red flags

• Diworsification: $9B FY26 M&A (Dragos, RunZero, NetRise per 8-K/narrative) — pivoting into OT cybersecurity and mid-market with no proven track record or disclosed margin targets
• $5B debt issuance (8-K July 10, 2026) to fund M&A while doing $7.5B buybacks — financial complexity obscures organic earnings quality
• Organic growth decelerating: 3% LCY Q3 FY26 (narrative); FY27 guide 3-6% LCY implies flattish to modestly improving — stalwart at 14x needs re-acceleration to justify multiple
• AI revenue opacity: management stopped disclosing AI bookings/revenue after Q1 FY26 (narrative caveats) — core growth thesis unverifiable
• Business optimization charges recurring: $615M in FY25, $308M in 9mo FY26 (10-Q 2026-06-18) — signals ongoing structural cost pressure not purely one-off
• Mid-market (Accenture Edge) and OT cyber platforms are launch-stage with no revenue, no margin targets, no acquisition playbook disclosed — pure assertion at this stage
• PEG 3.49 is squarely in 'hot stock overpay' territory by my framework, even with the stock down 37% from highs

Forensic Short-Seller (Chanos/Einhorn-style) — 🟡 watch · 52/100 · medium confidence

Accenture presents a materially cleaner earnings-quality picture than the typical forensic short target, but several specific patterns warrant adversarial scrutiny rather than a clean pass. The core Chanos test — net income vs. operating cash flow — actually works in Accenture's favor: OCF of $11.47B vs. net income of $7.68B for FY2025 (per fundamentals block), and FCF of $10.87B comfortably exceeds net income. This is the opposite of the classic accrual red flag. However, the 'watch' stance is warranted for the following reasons: (1) Recurring 'business optimization' charges that never fully stop — $1.063B in FY2023, $438M in FY2024, $615M in FY2025, and another $308M in the first half of FY2026 per the 10-Q filed 2026-06-18 — these are labeled one-time but have appeared in four consecutive years, which is definitional 'recurring non-recurring.' Management explicitly excludes them from adjusted EPS; the adjusted effective tax rate disclosures in the 10-Q (2026-06-18) confirm the non-GAAP exclusion pattern. (2) The $9B M&A spend in FY2026 alone (per earnings call narrative), with intangible assets amortization already jumping from $440M (FY2023) to $530M (FY2024) to $746M (FY2025) per the 10-K filed 2025-10-10 — amortization is rising sharply and will continue to climb. This creates a structural wedge between GAAP earnings and management's preferred adjusted metrics. (3) Receivables growth is noteworthy: per the 10-Q filed 2026-06-18, receivables grew from $11.87B (Aug 2024, per 10-K filed 2024-10-10) to $13.07B (Aug 2025) to $13.99B (May 2026). Revenue grew from ~$64.9B to ~$69.7B (FY2024 to FY2025, ~7.4%). Receivables grew from $11.87B to $13.07B over the same period (~10.1%), slightly outpacing revenue — worth monitoring but not yet alarming. The Q3 FY2026 receivables of $13.99B against 9-month revenue (implied ~$51B) suggests DSO is not deteriorating sharply. (4) The July 2026 debt issuance of ~$5B across five tranches (8-K filed 2026-07-10) — floating rate + fixed notes from 2029 to 2036 — represents a meaningful shift. Accenture's fundamentals show debt_to_equity as null and the valuation model uses net cash of -$9.65B (i.e., net cash positive as of Aug 2025), but the $5B raise to fund M&A changes the balance sheet character. Management confirmed they will 'access long-term debt for M&A liquidity while maintaining investment-grade rating.' This is not a debt wall situation, but it is a new financing dependence signal for a company that historically ran debt-light. (5) SBC/buyback treadmill: FY2026 buyback program raised to $7.5B (8-K filed 2026-06-23), yet share count has declined only modestly from ~658M (Sep 2025, per 10-K) toward ~637M (fundamentals). Significant buyback spend appears to be partially offsetting SBC dilution — the exact SBC figure is not disclosed in the excerpts, so I flag this as a missing data point rather than a confirmed finding. (6) AI bookings opacity: management stopped breaking out AI bookings after Q1 FY2026 (last reported $2.2B), per the narrative. This is a governance/transparency flag — when a company stops reporting a metric it previously promoted, forensic discipline demands the question: is the trend deteriorating? The 'kill question': this is NOT a short candidate in the classic Chanos sense — the cash flow generation is real and exceeds earnings, the balance sheet was net cash, and the business generates 15%+ FCF margins. The bear case is not insolvency or fraud; it is (a) the recurring restructuring charges mean true economic margins are ~200bps lower than reported adjusted figures, (b) the M&A-driven amortization surge will widen the GAAP vs. adjusted earnings gap materially through FY2027-2028, and (c) the $5B debt raise plus $9B M&A spend introduces integration and leverage risk in a slowing organic growth environment (3% LCY). The thesis is falsified if: AI bookings re-disclosure shows acceleration, Dragos/OT cyber integration generates disclosed margin accretion, and organic revenue reaccelerates to 5%+ LCY without further restructuring charges. AI disruption assessment: this is the most existential risk for the forensic lens. Accenture's consulting model is labor-arbitrage + expertise packaging — exactly what agentic AI threatens to commoditize. If AI agents can perform $200/hour consulting tasks at $5/hour, the TAM for human-delivered IT consulting shrinks. Management is betting they become the AI integrator/orchestrator rather than the displaced party, but the 'compressed timeline' headcount reductions and $344M severance (10-K filed 2025-10-10) suggest internal disruption is already underway. The forensic red flag is that productivity gains from AI may show up as margin expansion in near-term numbers while structural revenue erosion builds — masking the disruption until bookings cliff.

Key points

• OCF ($11.47B) and FCF ($10.87B) both exceed GAAP net income ($7.68B) in FY2025 — earnings quality passes the core Chanos test; no accrual inflation detected
• 'Business optimization' charges totaling $1.063B+$438M+$615M+$308M over four consecutive fiscal years (FY2023-FY2026 first half) are structurally recurring despite non-GAAP exclusion treatment — per 10-K filed 2025-10-10 and 10-Q filed 2026-06-18
• Intangible amortization surged from $441M (FY2023) to $530M (FY2024) to $746M (FY2025) per 10-K filed 2025-10-10, driven by serial acquisitions; the $9B FY2026 M&A spend will widen this GAAP drag further through FY2027-2028
• $5B debt issuance (8-K filed 2026-07-10) — including floating rate notes and fixed-rate tranches out to 2036 — marks a structural shift from historically debt-light balance sheet to acquisition-funded leverage
• Receivables grew ~10.1% (FY2024 to FY2025) vs revenue ~7.4%, a modest but trackable divergence; Q3 FY2026 receivables at $13.99B continue to grow per 10-Q filed 2026-06-18
• $7.5B buyback program (8-K filed 2026-06-23) partially offsets SBC dilution rather than delivering net shrinkage — shares outstanding declined only modestly from ~658M to ~637M; exact SBC figure not available in fact base
• AI bookings reporting discontinued after Q1 FY2026 per narrative — forensic flag when a company stops disclosing a previously promoted metric
• Management's adjusted EPS systematically excludes recurring restructuring, creating persistent GAAP-vs-adjusted wedge that flatters reported performance

Red flags

• Four consecutive years of 'one-time' business optimization charges ($2.4B+ cumulative FY2023-H1FY2026) that are consistently excluded from adjusted metrics — classic recurring non-recurring expense pattern
• Intangible amortization growing rapidly (+69% from FY2023 to FY2025 per 10-K filed 2025-10-10) from serial acquisitions; management's adjusted EPS excludes this real cash-deployment cost
• Discontinuation of AI bookings/revenue disclosure after Q1 FY2026 — when metrics disappear after promotion, forensic discipline demands skepticism about the underlying trend
• $5B debt raise (July 2026) to fund M&A while organic growth runs at 3% LCY introduces a leverage + integration risk combination not present in Accenture's historical profile
• FY2026 total M&A spend of $9B (per narrative) against $10.8-11.5B guided FCF is aggressive capital deployment leaving minimal margin for error; integration failures would show up in goodwill impairment — $5.32B goodwill added in FY2024 alone per 10-K filed 2024-10-10
• AI disruption structural risk: the labor-arbitrage consulting model is precisely what agentic AI threatens; $344M severance for 'compressed timeline' headcount reductions (10-K filed 2025-10-10) suggests internal recognition of this risk while P&L still shows expansion

Paul Singer — 🟡 watch · 48/100 · medium confidence

Accenture presents a mixed activist picture. The stock is trading at $183 well below the DCF intrinsic value of $274 (49% upside per the fact base), and 37% below its 52-week high. However, the classic Elliott self-help gap — a wide, specific, closeable discount between current management and optimal management — is only partially present here. Accenture is already a well-run, high-FCF business (FCF margin 15.6%, ROIC 26.2% per fundamentals), not a chronic underperformer with latent asset value being suppressed by a lazy board. The investment case is more 'good business at a temporarily depressed price' than 'broken conglomerate screaming for a catalyst.' That said, several activist pressure points exist and deserve scrutiny.

Self-help gap assessment: Operating margin at 14.7% (GAAP, FY2025 per 10-K) and guided to 15.8% for FY26 (+20bps) is credible but modest expansion. The narrative notes 8 consecutive quarters of margin expansion. Peer consulting firms (McKinsey private, IBM Consulting ~10%, Capgemini ~13-14%) suggest Accenture is already near the top of the listed peer range. There is no obvious margin-compression-vs-peers story to build a letter around. The gap is not wide enough to anchor a classic Elliott indictment.

Capital allocation as the indictment — this is the live concern: The $9B M&A spend in FY26 alone (Dragos, RunZero, NetRise, Alpha Health, Whaler per narrative) is a significant escalation. The July 2026 8-K confirms Accenture Capital issued ~$5B in senior notes (floating rate notes, 4.75% due 2029, 5.00% due 2031, 5.30% due 2033, 5.60% due 2036) to fund this. This is a company that historically ran net-cash (the DCF uses net cash of -$9.6B meaning net cash positive $9.65B per the valuation assumptions) now drawing on debt markets at meaningful coupons to fund a compressed acquisition strategy. The pattern — acquisition spree into an uncertain macro, obscured AI revenue metrics (stopped breaking out AI bookings after Q1 FY26 per narrative), and business optimization charges ($615M in FY25, $438M in FY24 per 10-K) — is exactly the kind of capital allocation record Elliott would scrutinize. R&D declined from $1.30B (FY23) to $817M (FY25) per the 10-K while M&A spending exploded — a potential red flag that organic innovation is being substituted with expensive acquisitions.

SOTP analysis: Accenture does not publish clean separable segment P&Ls by business type (consulting vs. managed services). The geographic segments (North America/EMEA/Asia Pacific) are revenue-disclosed but not margin-separated in the excerpts available. Without segment-level EBIT disclosure, a rigorous SOTP cannot be constructed from this fact base. The Dragos/RunZero/NetRise OT cybersecurity platform ($208M ARR, 48% growth per narrative) could theoretically be valued on SaaS multiples (25-40x ARR = $5-8B) vs. what Accenture paid, but exact acquisition price is not disclosed in the fact base. This is a missing data point that limits the activist case.

Capital structure and downside floor: Post-bond issuance, ACN now carries meaningful long-term debt (exact total not broken out in available excerpts, but the July 2026 offering alone was ~$5B). The FY2025 10-K shows operating cash flow of $11.47B and FCF of $10.87B, which comfortably covers the new debt service. Current ratio 1.41, cash $9.65B per fundamentals. The floor is real — this business generates prodigious cash and the bond markets just cleared $5B of new paper at investment-grade terms, suggesting no near-term distress risk. So the downside is protected by cash generation, not asset liquidation value.

Governance and levers: Accenture is incorporated in Ireland, annually elects directors (no staggered board visible in available filings), has a broad public float with no disclosed supervoting or founder control. The June 2026 8-K shows a $2B increase to share repurchase program (total $7.5B FY26) and a 10% dividend increase. The board is accessible and responsive to shareholder-friendly optics. This is favorable for an activist — no poison pill or dual-class structure evident. However, the company is not a chronic underperformer, which reduces the urgency argument for shareholder pressure.

AI disruption risk through the activist lens: This is the core bear case and the most important long-term risk. If AI automates substantial portions of consulting and managed services delivery, Accenture's 700,000+ headcount model faces structural margin compression — not from management failure but from industry disruption. Elliott would care about this because it potentially eliminates the floor (the business degrades, not management). The narrative is ambiguous: management claims AI is an enabler (larger client programs, new bookings categories), but skeptics note AI commoditizes exactly the labor arbitrage that built Accenture's scale. The stopping of AI revenue segmentation disclosure after Q1 FY26 is the kind of opacity that Elliott would flag publicly.

Falsifiable call: The activist thesis here would be: (1) halt the $9B FY26 acquisition spree and return excess capital — management has committed to $9.5B+ shareholder returns but is simultaneously levering up for M&A; (2) restore transparent AI revenue/bookings disclosure to allow market to price the AI tailwind independently; (3) explore separating the OT cybersecurity platform (Dragos+RunZero+NetRise) as a standalone entity once integrated, capturing a SaaS multiple premium vs. the consulting multiple ACN trades at (P/S of 1.61x). What would prove this wrong: if M&A integration proceeds on schedule with disclosed margin accretion, AI programs continue to scale (validated by resumed segmentation), and organic growth reaccelerates to 5-7% LCY — making the current strategy defensible.

Key points

• DCF intrinsic value $274 vs. $183 price = 49% upside; bear case $224 still implies 22% upside — real margin of safety present
• FCF $10.87B (FY25), ROIC 26.2%, net cash position pre-bond issuance — strong downside floor from cash generation
• No dual-class, staggered board, or founder control apparent — governance structure is activist-accessible
• $9B FY26 acquisition spend funded by $5B new bond issuance (4.75%-5.60% coupons, July 2026 8-K) — capital allocation escalation is an actionable Elliott pressure point
• R&D spend declined $1.30B (FY23) to $817M (FY25) per 10-K while M&A exploded — organic vs. inorganic trade-off is the indictment
• Business optimization charges $615M (FY25) + $438M (FY24) per 10-K suggest recurring restructuring, not one-time events — management credibility question
• Accenture stopped disclosing AI bookings/revenue after Q1 FY26 per narrative — opacity at exactly the moment transparency would support the premium valuation

Red flags

• No classic SOTP opportunity: Accenture does not report separable segment margins; no clean break-up path evident from available disclosures
• Self-help gap is narrow: operating margins already peer-leading among listed consultants; no obvious 300-500bps margin recapture story
• Serial acquisitions still in motion ($9B FY26): Elliott's own red flag — active acquisition spree before activist can intervene
• AI disruption could erode the business model structurally — not a management failure Elliott can fix, but an industry transition that permanently impairs the labor-arbitrage floor
• Integration risk on Dragos/RunZero/NetRise is unquantified: no profitability targets or margin accretion timeline disclosed in filings
• Consulting revenue growing only 1% LCY in Q3 FY26 per narrative — core business deceleration partially masked by managed services
• Managed services deals pushed to FY27 and federal business headwinds per narrative — near-term revenue visibility is poor, making timing of any activist campaign uncertain

Walter Schloss — 🔴 avoid · 22/100 · high confidence

Accenture is a high-quality, capital-light professional services firm, but it is categorically not a Schloss-style statistical bargain. The balance sheet is dominated by intangibles and goodwill rather than tangible hard assets, the stock trades at a large premium to any reasonable tangible book value, and the value thesis rests entirely on earnings/FCF power and a growth narrative — not on verifiable, conservative balance-sheet assets. From a Schloss perspective, the stock fails on nearly every primary criterion. Price-to-book is 3.64x (fundamentals block), and the book value itself is substantially inflated by goodwill accumulated from years of acquisitions (10-K filings note $5.3B of goodwill from fiscal 2024 acquisitions alone, and intangible assets amortization of $745M in FY2025 per the 2025 10-K). Tangible book value — after stripping goodwill and acquired intangibles — would be materially lower, likely negative or near zero on a per-share basis, making the effective price-to-tangible-book extremely elevated. The stock is also 37% below its 52-week high ($291.09 vs. $183.37 current), which is the one partially redeeming Schloss characteristic — it is beaten down. However, price depression alone is not sufficient when there is no hard-asset floor. The balance sheet carries $~5B in newly issued senior notes (8-K filed 2026-07-10 confirms $4.979B net proceeds from debt issuance), adding meaningful leverage where Accenture previously had essentially none — a Schloss red flag. Management is executing $9B in M&A in FY26 (per earnings narrative), which adds integration risk and goodwill, not tangible asset value. The DCF intrinsic value of $274/share with 49.5% upside is compelling for an earnings-based investor but is entirely a forecast-dependent, cash-flow-based valuation — precisely the type of analysis Schloss distrusted. FCF is strong ($10.87B, 15.6% margin per fundamentals), but Schloss bought assets, not earnings streams. Operating margin of ~15% and ROIC of 26% are exceptional operationally but reflect an asset-light model with no tangible asset backing. The P/S of 1.61x and P/FCF of 10.32x are low for a quality compounder but not cheap on Schloss terms. AI disruption is a double-edged sword here: Accenture is positioning as an AI-enabler (management commentary, Q3 FY26 call), but the bear case — that AI commoditizes the labor-intensive consulting model — is real and unresolved; this is a narrative/forecast risk, not an asset-protection story. Dividend (recently raised 10% to $1.63/quarter per narrative) and $7.5B buyback (8-K filed 2026-06-23) are positives for shareholder returns, but these are funded by earnings cash flow, not balance-sheet asset monetization. Bottom line: Accenture is the wrong shape of company for this lens — asset-light, goodwill-heavy, leverage newly added, value residing in intangible human capital and client relationships that cannot be appraised from the filings. A fine business; a poor Schloss candidate.

Key points

• Price-to-book of 3.64x (fundamentals) already elevated; tangible book after stripping goodwill and acquired intangibles likely near zero or negative, implying price-to-tangible-book is extremely high
• Stock is 37% below 52-week high — only Schloss-compatible feature — but price depression without a hard-asset floor provides no margin of safety
• $4.979B in new senior notes closed July 10, 2026 (8-K filed 2026-07-10) adds meaningful debt where balance sheet was previously clean; Schloss avoided leveraged balance sheets
• $9B FY26 acquisition spending (per earnings narrative) compounds goodwill accumulation; 2024 10-K shows $5.32B goodwill from FY24 acquisitions alone — assets are intangible and hard to independently appraise
• FCF of $10.87B and ROIC of 26% are outstanding operationally but rest entirely on earnings power and client relationships, not tangible assets — a forecast-dependent thesis Schloss distrusted
• Dividend raised 10% to $1.63/quarter and $7.5B buyback program (8-K 2026-06-23) are shareholder-friendly but funded by earnings, not asset monetization

Red flags

• Price-to-book 3.64x with tangible book likely deeply negative after goodwill removal — opposite of a Schloss net-asset bargain
• Value thesis is 100% earnings/FCF/growth dependent; no hard-asset floor independent of business performance
• New $5B debt issuance (8-K 2026-07-10) materially increases leverage — Schloss prized clean, debt-light balance sheets
• Goodwill and intangible assets dominate balance sheet; 2025 10-K shows intangible amortization $746M and depreciation $622M, confirming asset-light structure with acquisition-inflated book
• Consulting model faces genuine AI disruption risk (narrative section) that could impair the only real asset — human capital and client relationships — with no tangible fallback
• $9B M&A in a single year is complexity Schloss actively avoided; integration of Dragos, RunZero, NetRise untested and adds opaque contingent liabilities (redeemable noncontrolling interests of $494M per 10-Q filed 2026-06-18)

---

Fact base appendix

Price

• last_close: 183.37
• as_of: 2026-10-01
• high_52w: 291.09
• low_52w: 118.15
• range_source: provider
• pct_below_52w_high: -37.01
• return_52w_pct: -25.25

Fundamentals

• last_price: 183.37
• market_cap: 112211826875
• fifty_two_week_high: 291.09
• fifty_two_week_low: 118.15
• beta: 1.0918338
• currency: USD
• exchange: NEW YORK STOCK EXCHANGE, INC.
• sector: Technology
• industry: Technology
• price_source: finnhub
• bars: 1
• entity: Accenture plc
• fiscal_year: 2025
• revenue: 69672977000
• revenue_period: 2025-08-31
• net_income: 7678433000
• net_income_period: 2025-08-31
• operating_income: 10225664000
• operating_income_period: 2025-08-31
• operating_cash_flow: 11474399000
• operating_cash_flow_period: 2025-08-31
• capex: 600039000
• capex_period: 2025-08-31
• total_assets: 64698463000
• total_assets_period: 2025-11-30
• current_assets: 28066694000
• current_assets_period: 2025-11-30
• current_liabilities: 19896521000
• current_liabilities_period: 2025-11-30
• stockholders_equity: 30867503000
• stockholders_equity_period: 2025-11-30
• cash_and_equivalents: 9649405000
• cash_and_equivalents_period: 2025-11-30
• shares_outstanding: 637016143.0
• shares_wad: 615593409.0
• shares_wad_annual: 632435108.0
• operating_margin: 0.1468
• net_margin: 0.1102
• roe: 0.2488
• debt_to_equity: None
• current_ratio: 1.4106
• roic: 0.2617
• free_cash_flow: 10874360000
• fcf_margin: 0.1561
• pe_ratio: 14.61
• price_to_fcf: 10.32
• price_to_sales: 1.61
• revenue_cagr: 0.0419
• revenue_cagr_years: 3
• fundamentals_source: edgar_companyfacts
• market_cap_source: vendor_corroborated
• price_to_book: 3.64
• earnings_yield: 0.0997
• peg: 3.49

Filings reviewed

• 8-K (2026-10-01) https://www.sec.gov/Archives/edgar/data/1467373/000146737326000037/acn-20261001.htm
• 8-K (2026-07-10) https://www.sec.gov/Archives/edgar/data/1467373/000119312526300813/d181172d8k.htm
• 8-K (2026-06-23) https://www.sec.gov/Archives/edgar/data/1467373/000146737326000035/acn-20260623.htm
• 10-Q (2026-06-18) https://www.sec.gov/Archives/edgar/data/1467373/000146737326000032/acn-20260531.htm
• 8-K (2026-06-18) https://www.sec.gov/Archives/edgar/data/1467373/000146737326000031/acn-20260618.htm
• 10-Q (2026-03-19) https://www.sec.gov/Archives/edgar/data/1467373/000146737326000014/acn-20260228.htm
• 10-K (2025-10-10) https://www.sec.gov/Archives/edgar/data/1467373/000146737325000217/acn-20250831.htm
• 10-K (2024-10-10) https://www.sec.gov/Archives/edgar/data/1467373/000146737324000278/acn-20240831.htm

Other sources

• [news] Accenture PLC (ACN) Shares Surge 3.5% -- What GF Score of 87 Tells Investors - GuruFocus
• [news] Accenture PLC Cl A stock outperforms competitors on strong trading day - marketwatch.com
• [news] Accenture Q4 preview: SaaSpocalypse concerns persist, but AI tailwinds offer optimism (ACN:NYSE) - Seeking Alpha
• [news] Accenture PLC Stock (ACN) Moved Up by 3.18% on Sep 30: A Full Analysis - TradingKey
• [news] How To Earn $500 A Month From Accenture Stock Ahead Of Q4 Earnings - Benzinga
• [news] Accenture PLC Cl A stock outperforms competitors on strong trading day - MarketWatch
• [news] ACN Set to Report Q4 Earnings: Here's What Investors Should Know - TradingView
• [news] Accenture PLC Cl A stock underperforms Thursday when compared to competitors - MarketWatch
• [news] Here is What to Know Beyond Why Accenture PLC (ACN) is a Trending Stock - Yahoo Finance
• [news] Wall Street Expects Accenture plc (ACN) to Bounce Back Despite a 50% YTD Decline - Yahoo Finance
• [news] Why Accenture Stock Opened 18.9% Lower Today - The Motley Fool
• [news] Why Accenture Stock Opened 18.9% Lower Today - Yahoo Finance
• [news] Is Trending Stock Accenture PLC (ACN) a Buy Now? - Yahoo Finance
• [news] Is Trending Stock Accenture PLC (ACN) a Buy Now? - Yahoo Finance
• [news] Accenture shares jump 10% after quarterly revenue beat, upbeat outlook (ACN:NYSE) - Seeking Alpha
• [news] Accenture Shares Spike 10% Pre-Market On Q4 Earnings Beat, Upbeat Forecast - NDTV Profit
• [news] Accenture: Fiscal Q4 Earnings Snapshot - KVUE
• [news] Acuity, Accenture and 3 Stocks to Watch Heading Into Thursday - Benzinga
• [news] Accenture Plc Class A Actuals & Estimates (TURQUOISE:ACNN) - TradingView
• [news] Accenture Shares Plunged 50% This Year. Here's What Investors Need to Know. - The Motley Fool
• [news] Truist Cuts PT on Accenture (ACN) Following Q3 Report - Insider Monkey
• [news] Accenture Plc Class A Actuals & Estimates (FWB:CSA) - TradingView
• [news] Accenture Plc Class A Actuals & Estimates (NYSE:ACN) - TradingView
• [news] Why Accenture Stock Looks Undervalued After Eight Quarters of Expanding Operating Margins - TIKR.com
• [news] Is Accenture plc (ACN) A Good Stock To Buy Now? - Yahoo Finance
• [news] Accenture plc (ACN)’s Cash Machine Remains Strong. But Where Does Growth Come from? - Yahoo Finance
• [news] What's Going On With Accenture Stock Monday? - TradingView
• [news] Accenture PLC Has Huge Unusual Put and Call Options Activity After Lower Guidance - Barchart.com
• [news] Accenture PLC Cl A stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
• [discussion] [Bearish] $ACN PUTS will print
• [discussion] [Bullish] $ACN $IBM trending
• [discussion] $ACN

Accenture answered the AI-disruption trade this morning. Q4 revenue 18.7 billion vs 18.0 bil

• [discussion] [Bullish] $ACN can't believe i missed this at the bottom, beautiful setup
• [discussion] $ACN Q4 '26 Earnings Results & Recap

• Reported GAAP EPS of $3.29 up 8.58% YoY • Reported r

• [discussion] $PATH $ACN esrbinf woll fuel this mofo!
• [discussion] [Bullish] $ACN the long march back to $300 begins
• [discussion] $ACN Maybe helps SaaS a bit as well that seems to be capped to the upside for the past few weeks. $T
• [discussion] $ACN
• [discussion] $ACN
• [discussion] $ACN
• [discussion] [Bullish] $ACN wowwww yay more consultants
• [discussion] $ACN https://finance.yahoo.com/markets/stocks/articles/accenture-reports-fourth-quarter-full-1039007
• [discussion] $SPX closed Wednesday at 7651.54, the low of the day. Overnight, ES futures traded 7705 to 7767.75 a
• [discussion] $APP care $ACN Beat & up 13%?
• [discussion] $ACN I mean yeah it’s 10 PE now ACN is basically priced to lose 1/3-1/2 of its business at this poin
• [discussion] $ACN AI agents are structurally disrupting traditional enterprise software subscription economics, w
• [discussion] $ACN Tech needs big 'staff' to die to prove concept. It will be shorted to hell, even if th
• [discussion] [Bullish] The market is now pricing in -9.8% free cash flow growth annually for accenture over the n
• [discussion] [Bearish] $ACN It's called dead money, best case you just grind away for years around this level
• [discussion] $ACN I thought there would have been more of a bounce by now with the buyback news… but just the ste
• [discussion] Still holding $SERV $MU $ACN $U. The market is pricing in long-term conviction holding, but I think
• [discussion] [Bullish] $ACN
• [discussion] [Bullish] $ACN being bearish with a 5% dividend is way out there!
• [discussion] $ACN CRYPTO WINTER IN SUMMER
• [discussion] $ACN The managing directors have been awfully quiet on LinkedIn regarding all this. They’ve lost mil
• [discussion] $ACN strong after hours
• [discussion] $ACN initiated last Thursday and added across two times this week. love this one as a core long-term
• [discussion] $ACN Current Stock Price: $125.83 Contracts to trade: $125.0 ACN Jun 26 2026 Call Entry: $1.45 Exit:
• [discussion] [Bullish] $NOW $IGV $MSFT $ADBE $ACN Massive destruction of wealth across the software, technology
• [earnings_call] Accenture Q3 2026 Earnings Call |Mid-Market Edge Launch Outlined as AI Tailwinds Drive 9% EPS Growth

Data gaps

• Dataset completeness: 60 of 60 source documents were dropped to fit the prompt budget — the council did not see them.

---

Generated 2026-10-01T07:34:56 · est. cost $1.16